US6630328B2
(en)
|
1909-07-15 |
2003-10-07 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms
|
US4087685A
(en)
*
|
1977-01-11 |
1978-05-02 |
International Business Machines Corporation |
Fluorescent microanalytical system and method for detecting and identifying organic materials
|
US4171956A
(en)
*
|
1977-06-13 |
1979-10-23 |
General Electric Company |
Laser immunoassay
|
US4181441A
(en)
*
|
1977-12-07 |
1980-01-01 |
G. D. Searle & Co. |
Internal reflectance spectrometer
|
US4283382A
(en)
*
|
1977-12-28 |
1981-08-11 |
Eastman Kodak Company |
Fluorescent labels comprising rare earth chelates
|
US4344438A
(en)
*
|
1978-08-02 |
1982-08-17 |
The United States Of America As Represented By The Department Of Health, Education And Welfare |
Optical sensor of plasma constituents
|
US4222744A
(en)
*
|
1978-09-27 |
1980-09-16 |
Becton Dickinson & Company |
Assay for ligands
|
US4259313A
(en)
*
|
1978-10-18 |
1981-03-31 |
Eastman Kodak Company |
Fluorescent labels
|
US4275300A
(en)
*
|
1978-10-23 |
1981-06-23 |
Varian Associates, Inc. |
Fluorescent composition, a process for synthesizing the fluorescent composition, and methods of use of the fluorescent composition
|
NL8000173A
(nl)
*
|
1980-01-11 |
1981-08-03 |
Akzo Nv |
Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
|
US4297032A
(en)
*
|
1980-02-14 |
1981-10-27 |
The United States Of America As Represented By The Secretary Of The Navy |
Dark field surface inspection illumination technique
|
US4293310A
(en)
*
|
1980-03-14 |
1981-10-06 |
University Of Pittsburgh |
Photoelectrochemical immunoassay
|
US4368047A
(en)
*
|
1981-04-27 |
1983-01-11 |
University Of Utah Research Foundation |
Process for conducting fluorescence immunoassays without added labels and employing attenuated internal reflection
|
DE3135196A1
(de)
*
|
1981-09-05 |
1983-03-17 |
Merck Patent Gmbh, 6100 Darmstadt |
Verfahren, mittel und vorrichtung zur bestimmung biologischer komponenten
|
WO1983001112A1
(fr)
*
|
1981-09-18 |
1983-03-31 |
Carter, Timothy |
Procede de determination d'especes en solution avec un guide d'onde optique
|
US4582809A
(en)
*
|
1982-06-14 |
1986-04-15 |
Myron J. Block |
Apparatus including optical fiber for fluorescence immunoassay
|
US4447546A
(en)
*
|
1982-08-23 |
1984-05-08 |
Myron J. Block |
Fluorescent immunoassay employing optical fiber in capillary tube
|
AU570425B2
(en)
*
|
1982-12-21 |
1988-03-17 |
Applied Research Systems Ars Holding N.V. |
Assay technique
|
US4558014A
(en)
*
|
1983-06-13 |
1985-12-10 |
Myron J. Block |
Assay apparatus and methods
|
US4665020A
(en)
*
|
1984-05-30 |
1987-05-12 |
United States Department Of Energy |
Flow cytometer measurement of binding assays
|
AU583040B2
(en)
*
|
1984-06-13 |
1989-04-20 |
Applied Research Systems Ars Holding N.V. |
Devices for use in chemical test procedures
|
US4647544A
(en)
*
|
1984-06-25 |
1987-03-03 |
Nicoli David F |
Immunoassay using optical interference detection
|
US4681859A
(en)
*
|
1984-09-21 |
1987-07-21 |
Ortho Diagnostic Systems Inc. |
Fluorescence polarization immunoassay for heavy antigens
|
US4668636A
(en)
*
|
1984-11-06 |
1987-05-26 |
Battelle Memorial Institute |
Analytical assembly usable in apparatuses for optically determining species in solution
|
EP0184600B1
(fr)
*
|
1984-12-10 |
1990-03-14 |
Prutec Limited |
Méthode pour la détermination optique de paramètres d'espèces chimiques dans un échantillon liquide
|
DE3480490D1
(en)
*
|
1984-12-10 |
1989-12-21 |
Prutec Ltd |
Optical test probe and apparatus for optically determining species in solution
|
US4680275A
(en)
*
|
1985-02-11 |
1987-07-14 |
Becton, Dickinson And Company |
Homogeneous fluorescence immunoassay using a light absorbing material
|
US5830769A
(en)
*
|
1985-03-18 |
1998-11-03 |
Wieder; Irwin |
Homogeneous fluorassay methods employing fluorescent background rejection and water-soluble rare earth metal chelates
|
US4716121A
(en)
*
|
1985-09-09 |
1987-12-29 |
Ord, Inc. |
Fluorescent assays, including immunoassays, with feature of flowing sample
|
JPH01502131A
(ja)
*
|
1986-01-14 |
1989-07-27 |
レビン ハーマン ダブリュ |
エバネッセント波背景螢光/吸光度の検出
|
US4925804A
(en)
*
|
1986-06-17 |
1990-05-15 |
Baxter International Inc. |
Interligand metal transfer assay
|
WO1987007955A1
(fr)
|
1986-06-17 |
1987-12-30 |
Baxter Travenol Laboratories, Inc. |
Procede de fluoroanalyse homogene mettant en oeuvre le rejet de fonds fluorescents et des fluorophores de chelate hydrosoluble de metaux de terre rare
|
US5017009A
(en)
*
|
1986-06-26 |
1991-05-21 |
Ortho Diagnostic Systems, Inc. |
Scattered total internal reflectance immunoassay system
|
JP2591750B2
(ja)
*
|
1986-06-26 |
1997-03-19 |
オ−ソ・ダイアグノステイツク・システムズ・インコ−ポレ−テツド |
免疫分析システム
|
CA1340806C
(fr)
*
|
1986-07-02 |
1999-11-02 |
James Merrill Prober |
Methode, systeme et reactifs pour le sequencage de l'adn
|
BE1000572A4
(fr)
*
|
1987-05-20 |
1989-02-07 |
Block Myron J |
Cellule rta, appareil et procede pour titrer un polynucleotide dans un liquide.
|
US4979821A
(en)
*
|
1988-01-27 |
1990-12-25 |
Ortho Diagnostic Systems Inc. |
Cuvette for receiving liquid sample
|
US5095213A
(en)
*
|
1988-11-03 |
1992-03-10 |
Syntex (U.S.A.) Inc. |
Method of using an opaque plastic microscope slide for epi-fluorescent microscopy
|
US5925525A
(en)
*
|
1989-06-07 |
1999-07-20 |
Affymetrix, Inc. |
Method of identifying nucleotide differences
|
US6416952B1
(en)
|
1989-06-07 |
2002-07-09 |
Affymetrix, Inc. |
Photolithographic and other means for manufacturing arrays
|
US6551784B2
(en)
|
1989-06-07 |
2003-04-22 |
Affymetrix Inc |
Method of comparing nucleic acid sequences
|
US6955915B2
(en)
*
|
1989-06-07 |
2005-10-18 |
Affymetrix, Inc. |
Apparatus comprising polymers
|
US6309822B1
(en)
|
1989-06-07 |
2001-10-30 |
Affymetrix, Inc. |
Method for comparing copy number of nucleic acid sequences
|
US5424186A
(en)
|
1989-06-07 |
1995-06-13 |
Affymax Technologies N.V. |
Very large scale immobilized polymer synthesis
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
US6406844B1
(en)
|
1989-06-07 |
2002-06-18 |
Affymetrix, Inc. |
Very large scale immobilized polymer synthesis
|
US6346413B1
(en)
|
1989-06-07 |
2002-02-12 |
Affymetrix, Inc. |
Polymer arrays
|
US5800992A
(en)
|
1989-06-07 |
1998-09-01 |
Fodor; Stephen P.A. |
Method of detecting nucleic acids
|
US20060194258A1
(en)
*
|
1989-06-07 |
2006-08-31 |
Affymetrix, Inc. |
Polypeptide array synthesis
|
US6919211B1
(en)
|
1989-06-07 |
2005-07-19 |
Affymetrix, Inc. |
Polypeptide arrays
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
US5018866A
(en)
*
|
1989-09-12 |
1991-05-28 |
Packard Instrument Company |
Method and apparatus for performing high sensitivity fluorescence measurements
|
US6506558B1
(en)
|
1990-03-07 |
2003-01-14 |
Affymetrix Inc. |
Very large scale immobilized polymer synthesis
|
US5143066A
(en)
*
|
1990-05-08 |
1992-09-01 |
University Of Pittsburgh |
Optical fiber sensors for continuous monitoring of biochemicals and related method
|
US5350697A
(en)
*
|
1990-08-28 |
1994-09-27 |
Akzo N.V. |
Scattered light detection apparatus
|
DE4030836A1
(de)
*
|
1990-09-28 |
1992-04-02 |
Kim Yoon Ok |
Vorrichtung zur qualitativen und/oder quantitativen bestimmung der zusammensetzung einer zu analysierenden probe
|
AU1248292A
(en)
*
|
1990-12-06 |
1992-07-08 |
Affymax Technologies N.V. |
Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
|
US5192510A
(en)
*
|
1991-01-30 |
1993-03-09 |
E. I. Du Pont De Nemours And Company |
Apparatus for performing fluorescent assays which separates bulk and evanescent fluorescence
|
US6468740B1
(en)
|
1992-11-05 |
2002-10-22 |
Affymetrix, Inc. |
Cyclic and substituted immobilized molecular synthesis
|
WO1994000761A1
(fr)
*
|
1992-06-26 |
1994-01-06 |
Daikin Industries, Ltd. |
Instrument de mesure optique
|
US6256522B1
(en)
|
1992-11-23 |
2001-07-03 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Sensors for continuous monitoring of biochemicals and related method
|
US5677196A
(en)
*
|
1993-05-18 |
1997-10-14 |
University Of Utah Research Foundation |
Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
|
US5512492A
(en)
|
1993-05-18 |
1996-04-30 |
University Of Utah Research Foundation |
Waveguide immunosensor with coating chemistry providing enhanced sensitivity
|
US5919712A
(en)
|
1993-05-18 |
1999-07-06 |
University Of Utah Research Foundation |
Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
|
US5552272A
(en)
*
|
1993-06-10 |
1996-09-03 |
Biostar, Inc. |
Detection of an analyte by fluorescence using a thin film optical device
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US5413939A
(en)
*
|
1993-06-29 |
1995-05-09 |
First Medical, Inc. |
Solid-phase binding assay system for interferometrically measuring analytes bound to an active receptor
|
US5684144A
(en)
*
|
1993-07-28 |
1997-11-04 |
University Of North Texas |
Escherichia coli csrA gene, protein encoded thereby, and methods of use thereof
|
US5453381A
(en)
*
|
1993-12-10 |
1995-09-26 |
Lipton; Stewart |
Method for adhering fecal samples to slides
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US5485277A
(en)
*
|
1994-07-26 |
1996-01-16 |
Physical Optics Corporation |
Surface plasmon resonance sensor and methods for the utilization thereof
|
DE69521002T3
(de)
|
1994-08-12 |
2010-02-25 |
The University Of Utah Research Foundation, Salt Lake City |
Mutationen des mit 17q verbundenen Ovarial- und Brustkrebs Empfindlichkeitsgens
|
WO1996005307A2
(fr)
|
1994-08-12 |
1996-02-22 |
Myriad Genetics, Inc. |
Gene de susceptibilite au cancer des ovaires et du sein lie a 17q
|
US8236493B2
(en)
*
|
1994-10-21 |
2012-08-07 |
Affymetrix, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US6974666B1
(en)
*
|
1994-10-21 |
2005-12-13 |
Appymetric, Inc. |
Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
|
US5633149A
(en)
|
1994-12-07 |
1997-05-27 |
Incyte Pharmaceuticals, Inc. |
Polynucleotide encoding novel chemokine expressed in inflamed adenoid
|
US7005509B1
(en)
|
1995-02-17 |
2006-02-28 |
Incyte Corporation |
Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
|
US5814565A
(en)
*
|
1995-02-23 |
1998-09-29 |
University Of Utah Research Foundation |
Integrated optic waveguide immunosensor
|
ATE483733T1
(de)
|
1995-06-14 |
2010-10-15 |
Univ California |
Hochaffine humane antikörper gegen tumorantigene
|
US5837492A
(en)
|
1995-12-18 |
1998-11-17 |
Myriad Genetics, Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
AU1461597A
(en)
|
1995-12-18 |
1997-07-14 |
Endorecherche Inc. |
Chromosome 13-linked breast cancer susceptibility gene
|
US7282327B2
(en)
*
|
1996-01-23 |
2007-10-16 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20010018514A1
(en)
*
|
1998-07-31 |
2001-08-30 |
Mcgall Glenn H. |
Nucleic acid labeling compounds
|
EP0880598A4
(fr)
*
|
1996-01-23 |
2005-02-23 |
Affymetrix Inc |
Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite
|
US7291463B2
(en)
*
|
1996-01-23 |
2007-11-06 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US7423143B2
(en)
*
|
1996-01-23 |
2008-09-09 |
Affymetrix. Inc. |
Nucleic acid labeling compounds
|
US6965020B2
(en)
|
1996-01-23 |
2005-11-15 |
Affymetrix, Inc. |
Nucleic acid labeling compounds
|
US20040210045A1
(en)
*
|
1996-01-23 |
2004-10-21 |
Mcgall Glenn |
Nucleic acid labeling compounds
|
US6864059B2
(en)
*
|
1996-01-23 |
2005-03-08 |
Affymetrix, Inc. |
Biotin containing C-glycoside nucleic acid labeling compounds
|
US6924094B1
(en)
|
1996-02-08 |
2005-08-02 |
Affymetrix, Inc. |
Chip-based species identification and phenotypic characterization of microorganisms
|
EP1728875A3
(fr)
|
1996-02-08 |
2007-05-09 |
Affymetrix, Inc. |
Spéciation de micro-organismes à partir de micro plaquettes et caractérisation des phénotypes de ceux-ci
|
EP0937159A4
(fr)
|
1996-02-08 |
2004-10-20 |
Affymetrix Inc |
Speciation de micro-organismes a partir de microplaquettes et caracterisation des phenotypes de ceux-ci
|
US5854863A
(en)
*
|
1996-03-15 |
1998-12-29 |
Erb; Judith |
Surface treatment and light injection method and apparatus
|
WO1997034629A1
(fr)
*
|
1996-03-22 |
1997-09-25 |
University Of Georgia Research Foundation, Inc. |
Compositions immunogenes comprenant des peptides porphyromonas gingivalis et procedes
|
US5882644A
(en)
*
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
US6586193B2
(en)
*
|
1996-04-25 |
2003-07-01 |
Genicon Sciences Corporation |
Analyte assay using particulate labels
|
BR9710836A
(pt)
*
|
1996-04-25 |
2000-10-24 |
Spectrametrix Inc |
Ensaio de analitos usando marcas em partìculas
|
IL127193A
(en)
|
1996-05-22 |
2006-10-31 |
Viventia Biotech Inc |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments and use thereof for the prophylaxis and detection of cancers
|
US6331275B1
(en)
|
1996-07-08 |
2001-12-18 |
Burstein Technologies, Inc. |
Spatially addressable, cleavable reflective signal elements, assay device and method
|
US20050069923A1
(en)
*
|
1996-07-08 |
2005-03-31 |
Mullis Kary Banks |
Dual bead assays using cleavable spacers and/or ligation to improve specificity and sensitivity including related methods and apparatus
|
US6342349B1
(en)
|
1996-07-08 |
2002-01-29 |
Burstein Technologies, Inc. |
Optical disk-based assay devices and methods
|
IL151635A0
(en)
*
|
1996-07-08 |
2003-04-10 |
Burstein Technologies Inc |
Cleavable signal element device for diagnostic applications and assay method
|
US20050214827A1
(en)
*
|
1996-07-08 |
2005-09-29 |
Burstein Technologies, Inc. |
Assay device and method
|
DE19628002C1
(de)
|
1996-07-11 |
1997-12-18 |
Inst Chemo Biosensorik |
Vorrichtung und Verfahren zur Durchführung von Fluoreszenzimmunotests
|
ES2308787T3
(es)
|
1996-08-16 |
2008-12-01 |
Schering Corporation |
Antigenos de superficie de celular de mamiferos; reactivos relacionados.
|
CA2266325C
(fr)
|
1996-09-24 |
2012-07-17 |
Lxr Biotechnology, Inc. |
Famille de genes codant les peptides lies a l'apoptose, peptides ainsi codes et leurs procedes d'utilisation
|
US20070299005A1
(en)
*
|
1996-09-24 |
2007-12-27 |
Tanox, Inc. |
Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
|
US6808880B2
(en)
*
|
1996-10-01 |
2004-10-26 |
Geron Corporation |
Method for detecting polynucleotides encoding telomerase
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
US6093809A
(en)
*
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
EP2213740A1
(fr)
|
1996-10-01 |
2010-08-04 |
The Regents of the University of Colorado |
Sous-unité catalytique de la télomérase humaine
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
US6610839B1
(en)
*
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
GB9907461D0
(en)
|
1999-03-31 |
1999-05-26 |
King S College London |
Neurite regeneration
|
DE122010000046I1
(de)
|
1996-12-13 |
2011-05-05 |
Schering Corp |
Oberflächenantigene aus Säugern
|
DK0966533T3
(da)
|
1997-02-07 |
2010-01-04 |
Us Gov Health & Human Serv |
Aktivitetsafhængig neurotrof faktor III (ADNF III).
|
US6686208B2
(en)
*
|
1997-03-18 |
2004-02-03 |
Institut Fur Chemo- Und Biosensorik Munster E.V. |
Device and method for carrying out fluoresence immunotests
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
US20050013825A1
(en)
*
|
1997-04-18 |
2005-01-20 |
Geron Corporation |
Vaccine containing the catalytic subunit of telomerase for treating cancer
|
DK1798288T3
(da)
|
1997-05-07 |
2010-01-04 |
Schering Corp |
Humane Toll-lignende receptorproteiner, relaterede reagenser og fremgangsmåder
|
US7115722B1
(en)
|
1997-05-22 |
2006-10-03 |
Viventia Biotech, Inc. |
Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
US20020122807A1
(en)
*
|
1998-07-07 |
2002-09-05 |
Dan Michael D. |
Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
|
SK252000A3
(en)
|
1997-07-09 |
2000-09-12 |
Schering Corp |
PURIFIED PROTEIN OR RECOMBINANT POLYPEPTIDE DCMP1 AND DCMP2,ì (54) FUSED PROTEIN, BIND COMPOUND, DCMP1 OR DCMP2 ENCODING NU
|
EP0927266A1
(fr)
|
1997-07-11 |
1999-07-07 |
The University Of North Texas Health Science Center At Fort Worth |
GENE $i(csrB) DE L'$i(ESCHERICHIA COLI), ARN CODE PAR CE GENE ET PROCEDES D'UTILISATION
|
US6762039B2
(en)
*
|
1997-07-15 |
2004-07-13 |
Genencor International, Inc. |
Bacillus subtillis with an inactivated cysteine protease-1
|
US20030157642A1
(en)
*
|
1997-07-15 |
2003-08-21 |
Caldwell Robert M. |
Increasing production of proteins in gram-positive microorganisms
|
US6723550B1
(en)
*
|
1997-07-15 |
2004-04-20 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6506579B1
(en)
|
1997-07-15 |
2003-01-14 |
Genencor International, Inc. |
Increasing production of proteins in gram-positive microorganisms using SecG
|
US6521421B1
(en)
|
1997-07-16 |
2003-02-18 |
Genencor International, Inc. |
Expression vectors encoding Bacillus subtilis disulfide bond isomerase and methods of secreting proteins in gram-positive microorganisms using the same
|
ZA986596B
(en)
|
1997-07-25 |
1999-02-08 |
Schering Corp |
Mammalian cytokine related reagents
|
ATE523593T1
(de)
|
1997-08-01 |
2011-09-15 |
Schering Corp |
Membranproteine aus säugetierzellen und verwandte reagentien
|
US6180411B1
(en)
|
1997-08-01 |
2001-01-30 |
The Regents Of The University Of California |
Light-triggered indicators that memorize analyte concentrations
|
US7252950B1
(en)
|
1997-09-04 |
2007-08-07 |
The Regents Of The University Of California |
Assays for detecting modulators of cytoskeletal function
|
US6521440B1
(en)
|
1997-09-15 |
2003-02-18 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6300117B1
(en)
*
|
1997-09-15 |
2001-10-09 |
Genencor International, Inc. |
Proteases from gram-positive organisms
|
US6222619B1
(en)
|
1997-09-18 |
2001-04-24 |
University Of Utah Research Foundation |
Diagnostic device and method
|
US7378244B2
(en)
*
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
US6316241B1
(en)
*
|
1997-11-20 |
2001-11-13 |
Genencor International, Inc. |
Alpha/beta hydrolase-fold enzymes
|
GB9724627D0
(en)
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Gram positive microorganism formate pathway
|
GB9724629D0
(en)
*
|
1997-11-20 |
1998-01-21 |
Genencor Int Bv |
Alpha/beta hydrolase-fold enzymes
|
US6599731B1
(en)
|
1997-12-30 |
2003-07-29 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
GB9727470D0
(en)
*
|
1997-12-30 |
1998-02-25 |
Genencor Int Bv |
Proteases from gram positive organisms
|
US6528255B1
(en)
*
|
1997-12-30 |
2003-03-04 |
Genencor International, Inc. |
Proteases from gram positive organisms
|
US6465186B1
(en)
|
1997-12-30 |
2002-10-15 |
Genecor International, Inc. |
Proteases from gram positive organisms
|
US6780609B1
(en)
|
1998-10-23 |
2004-08-24 |
Genome Therapeutics Corporation |
High bone mass gene of 1.1q13.3
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
US6673914B1
(en)
|
1998-01-22 |
2004-01-06 |
John Wayne Cancer Institute |
Human tumor-associated gene
|
US6596501B2
(en)
|
1998-02-23 |
2003-07-22 |
Fred Hutchinson Cancer Research Center |
Method of diagnosing autoimmune disease
|
CN1249226C
(zh)
|
1998-03-04 |
2006-04-05 |
金克克国际有限公司 |
支链淀粉酶的修饰形式
|
CA2323812C
(fr)
|
1998-03-20 |
2011-05-10 |
The Curators Of The University Of Missouri |
Diagnostic precoce de grossesse au moyen de glycoproteines associees a la grossesse
|
CA2326392A1
(fr)
*
|
1998-03-30 |
1999-10-07 |
Epitope, Inc. |
Dispositif de recueil pour dosage de fluides en une seule operation
|
US8062908B2
(en)
*
|
1999-03-29 |
2011-11-22 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6303081B1
(en)
*
|
1998-03-30 |
2001-10-16 |
Orasure Technologies, Inc. |
Device for collection and assay of oral fluids
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
CA2323058C
(fr)
*
|
1998-03-31 |
2011-03-29 |
Genzyme Corporation |
Methodes de diagnostic et de traitement du cancer du poumon par detection de la surexpression proto-oncogene
|
US7108968B2
(en)
*
|
1998-04-03 |
2006-09-19 |
Affymetrix, Inc. |
Mycobacterial rpoB sequences
|
US6699969B1
(en)
|
1998-04-14 |
2004-03-02 |
The Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
US6872537B1
(en)
|
1998-04-14 |
2005-03-29 |
Regents Of The University Of California |
Assays for the detection of microtubule depolymerization inhibitors
|
WO1999053295A1
(fr)
|
1998-04-14 |
1999-10-21 |
The Regents Of The University Of California |
Dosages de detection d'inhibiteurs de depolymerisation de microtubules
|
EP1097378A2
(fr)
*
|
1998-07-21 |
2001-05-09 |
Burstein Laboratories Inc. |
Dispositifs de dosage utilisant des disques optiques et methodes correspondantes
|
DK1098988T4
(da)
*
|
1998-07-21 |
2007-09-03 |
Danisco |
Födevare
|
SE9803099D0
(sv)
|
1998-09-13 |
1998-09-13 |
Karolinska Innovations Ab |
Nucleic acid transfer
|
EP1115867A1
(fr)
|
1998-09-21 |
2001-07-18 |
Schering Corporation |
Interleukine humaine b50, ses utilisations therapeutiques
|
EP0997476A3
(fr)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Anticorps contre un antigène de cellules Langerhans mammifères et leurs utilisations
|
US6545264B1
(en)
|
1998-10-30 |
2003-04-08 |
Affymetrix, Inc. |
Systems and methods for high performance scanning
|
ES2333694T3
(es)
|
1999-01-11 |
2010-02-26 |
Schering Corporation |
Citoquinas de mamiferos relacionados con la interleuquina-17.polinucleotido que las codifican y sus instalaciones.
|
US6156515A
(en)
*
|
1999-02-09 |
2000-12-05 |
Urocor, Inc. |
Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
|
CA2366706A1
(fr)
|
1999-03-11 |
2000-09-14 |
Schering Corporation |
Cytokines de mammifere : reactifs et procedes associes
|
EE04249B1
(et)
*
|
1999-04-21 |
2004-02-16 |
Asper O� |
Meetod biopolümeermaatriksi lugemiseks ja fluorestsentsdetektor
|
KR101018134B1
(ko)
|
1999-05-13 |
2011-02-25 |
쉐링 코포레이션 |
Ox2 수용체 동족체
|
DK2385124T3
(da)
|
1999-05-14 |
2013-11-18 |
Arbor Vita Corp |
Peptider, eller peptid-analoger, til modulering af bindingen af et PDZ protein og et PL protein
|
ES2322791T5
(es)
|
1999-06-01 |
2013-11-29 |
Merck Sharp & Dohme Corp. |
Proteínas receptoras de mamíferos; reactivos y métodos relacionados
|
SI1200592T1
(sl)
|
1999-07-30 |
2010-01-29 |
Schering Corp |
Sesalski citokini; sorodni reagenti
|
ES2219962T3
(es)
|
1999-08-24 |
2004-12-01 |
Leuze Electronic Gmbh + Co Kg |
Dispositivo para la realizacion de inmunoensayos.
|
EP3184637A1
(fr)
|
1999-09-09 |
2017-06-28 |
Merck Sharp & Dohme Corp. |
Utilisations de complexes d'interleukine-12 p40 et d'interleukine b30 mammaliennes, anticorps, dans des compositions pharmaceutiques
|
US7668658B2
(en)
*
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
WO2001038352A2
(fr)
|
1999-11-24 |
2001-05-31 |
Schering Corporation |
Procedes d'inhibition de metastases
|
ATE411522T1
(de)
|
1999-12-06 |
2008-10-15 |
Univ Illinois |
Hochaffine t-zellrezeptorproteine und verfahren
|
US6376180B1
(en)
*
|
1999-12-09 |
2002-04-23 |
Pharmacia & Upjohn Company |
Methods of identifying compounds that bind to target species under isothermal denaturing conditions
|
US6544792B1
(en)
|
1999-12-21 |
2003-04-08 |
Genencor International, Inc. |
Production of secreted polypeptides
|
JP3783826B2
(ja)
*
|
2000-01-17 |
2006-06-07 |
横河電機株式会社 |
バイオチップ読み取り装置
|
DE10003734A1
(de)
*
|
2000-01-28 |
2001-08-02 |
Bosch Gmbh Robert |
Detektionsverfahren und -vorrichtung
|
AU3988401A
(en)
*
|
2000-02-25 |
2001-09-03 |
Ludwig Inst Cancer Res |
Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins
|
US7829313B2
(en)
*
|
2000-03-24 |
2010-11-09 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
US7875442B2
(en)
*
|
2000-03-24 |
2011-01-25 |
Eppendorf Array Technologies |
Identification and quantification of a plurality of biological (micro)organisms or their components
|
WO2006053770A1
(fr)
|
2004-11-18 |
2006-05-26 |
Eppendorf Array Technologies |
Pcr en temps reel de cibles sur un microreseau
|
US8288128B2
(en)
*
|
2004-11-18 |
2012-10-16 |
Eppendorf Array Technologies S.A. |
Real-time quantification of multiple targets on a micro-array
|
US20030108927A1
(en)
*
|
2000-04-03 |
2003-06-12 |
Kathryn Leishman |
Compositions and methods for the prevention, treatment and detection of tuberculosis and other diseases
|
MXPA02010275A
(es)
|
2000-04-18 |
2003-04-25 |
Schering Corp |
Usos de citocina; composiciones; metodos.
|
EP2275548A1
(fr)
|
2000-05-10 |
2011-01-19 |
Schering Corporation |
Protéines de récepteur de mammifère; réactifs et procédés associés
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
HUP0302240A2
(hu)
|
2000-05-25 |
2003-10-28 |
Schering Corp. |
Humán receptorfehérjék, ezekkel kapcsolatos reagensek és eljárások
|
WO2005000087A2
(fr)
*
|
2003-06-03 |
2005-01-06 |
Chiron Corporation |
Produits genetiques exprimes de facon differentielle dans des cellules cancereuses du colon et leurs methodes d'utilisation ii
|
WO2001096604A2
(fr)
*
|
2000-06-12 |
2001-12-20 |
Genicon Sciences Corporation |
Analyse de polymorphismes genetiques a l'aide de marqueurs detectables a la lumiere diffusee
|
US6958214B2
(en)
*
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
GB0020498D0
(en)
|
2000-08-18 |
2000-10-11 |
Sterix Ltd |
Compound
|
EP1315743B1
(fr)
|
2000-09-08 |
2012-11-07 |
Merck Sharp & Dohme Corp. |
Genes mammaliens, reactifs et methodes associes
|
WO2002020722A2
(fr)
|
2000-09-08 |
2002-03-14 |
Board Of Regents, The University Of Texas Syste |
Procedes et compositions utilises pour le ciblage in vitro
|
US6673623B1
(en)
|
2000-09-12 |
2004-01-06 |
Novocure, Inc. |
Methods and compositions that control lipid production
|
AU2001292749A1
(en)
|
2000-09-18 |
2002-03-26 |
Genencor International, Inc. |
Twin-arginine translocation in bacillus
|
US7045283B2
(en)
|
2000-10-18 |
2006-05-16 |
The Regents Of The University Of California |
Methods of high-throughput screening for internalizing antibodies
|
EP1410044A2
(fr)
*
|
2000-11-08 |
2004-04-21 |
Burstein Technologies, Inc. |
Systeme interactif pour l'analyse d'echantillons biologiques et le traitement de l'information y relative et son utilisation
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
WO2002044695A1
(fr)
*
|
2000-11-16 |
2002-06-06 |
Burstein Technologies, Inc. |
Methodes et appareils destines a la detection et au denombrement de lymphocytes utilisant des biodisques optiques
|
US20020172980A1
(en)
*
|
2000-11-27 |
2002-11-21 |
Phan Brigitte Chau |
Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
|
US20030003464A1
(en)
*
|
2000-11-27 |
2003-01-02 |
Phan Brigitte C. |
Dual bead assays including optical biodiscs and methods relating thereto
|
US20040248093A1
(en)
*
|
2000-11-27 |
2004-12-09 |
Coombs James Howard |
Magneto-optical bio-discs and systems including related methods
|
WO2002044366A2
(fr)
*
|
2000-11-29 |
2002-06-06 |
Lynkeus Biotech Gmbh |
Nouvelles proteines humaines specifiques de la retine c7orf9, c12orf7, mpp4 et f379
|
US6760298B2
(en)
*
|
2000-12-08 |
2004-07-06 |
Nagaoka & Co., Ltd. |
Multiple data layer optical discs for detecting analytes
|
WO2002046400A2
(fr)
*
|
2000-12-08 |
2002-06-13 |
The Board Of Trustees Of The University Of Illinois |
Proteines mutantes du complexe majeur d'histocompatibilite de classe ii
|
WO2002046762A2
(fr)
*
|
2000-12-08 |
2002-06-13 |
Burstein Technologies, Inc. |
Ensembles disques optiques pour l'execution de dosages biologiques
|
GB0101762D0
(en)
*
|
2001-01-23 |
2001-03-07 |
Medical Res Council |
Method
|
EP1488208A4
(fr)
*
|
2001-02-23 |
2008-05-28 |
Invitrogen Corp |
Procedes permettant d'etendre l'echelle dynamique dans des dosages d'analytes
|
CA2440615A1
(fr)
|
2001-03-12 |
2002-09-19 |
Affymetrix, Inc. |
Composes de marquage d'acide nucleique
|
US20030104410A1
(en)
*
|
2001-03-16 |
2003-06-05 |
Affymetrix, Inc. |
Human microarray
|
US20030220475A1
(en)
*
|
2001-04-03 |
2003-11-27 |
Fields Howard A. |
Neutralizing immunogenic hev polypepetides
|
US7618789B2
(en)
*
|
2001-04-06 |
2009-11-17 |
The United States Of America As Represented By The Secretary Of Department Of Health And Human Services |
Use of semenogelin in the diagnosis, prognosis and treatment of cancer
|
AU2002368023A1
(en)
*
|
2001-05-16 |
2004-03-04 |
Burstein Technologies, Inc. |
Variable sampling for rendering pixelization of analysis results in optical bio-disc assembly
|
CN100591212C
(zh)
|
2001-05-18 |
2010-02-24 |
丹尼斯科有限公司 |
改善生面团和面包质量的方法
|
ATE413884T1
(de)
|
2001-05-22 |
2008-11-15 |
Merck & Co Inc |
Beta-secretase-substrat und seine verwendung
|
US20070190534A1
(en)
*
|
2001-06-11 |
2007-08-16 |
Genesis Genomics Inc. |
Mitochondrial sites and genes associated with prostate cancer
|
US20040226348A1
(en)
*
|
2001-07-24 |
2004-11-18 |
Phillip Bruce |
Magnetic assisted detection of magnetic beads using optical disc drives
|
WO2003012030A2
(fr)
*
|
2001-08-01 |
2003-02-13 |
University Of Utah, Technology Transfer Office |
Inhibiteurs et activateurs selectifs d'isoformes de phosphodiesterases nucleotidiques cycliques pde3
|
US6833441B2
(en)
|
2001-08-01 |
2004-12-21 |
Abmaxis, Inc. |
Compositions and methods for generating chimeric heteromultimers
|
US20030082596A1
(en)
*
|
2001-08-08 |
2003-05-01 |
Michael Mittmann |
Methods of genetic analysis of probes: test3
|
US20060073530A1
(en)
*
|
2001-08-15 |
2006-04-06 |
Olaf Schneewind |
Methods and compositions involving sortase B
|
US20030129665A1
(en)
*
|
2001-08-30 |
2003-07-10 |
Selvan Gowri Pyapali |
Methods for qualitative and quantitative analysis of cells and related optical bio-disc systems
|
WO2003021222A2
(fr)
*
|
2001-08-31 |
2003-03-13 |
Burstein Technologies, Inc. |
Ensembles a couche de capture destines a des analyses cellulaires, comportant des disques d'analyse optiques, et procedes correspondants
|
US7718387B2
(en)
|
2001-09-20 |
2010-05-18 |
Board Of Regents, The University Of Texas System |
Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
|
US7393696B2
(en)
|
2001-09-28 |
2008-07-01 |
Aspenbio Pharma, Inc. |
Bovine pregnancy test
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
EP1439857B1
(fr)
|
2001-10-12 |
2009-02-25 |
Schering Corporation |
UTILISATION D'ANTICORPS BISPECIFIQUES RECONNAISSANT LE RECEPTEUR D'ACTIVATION FcEpsilon RI ET LE RECEPTEUR D'INHIBITION OX2Ra (CD200Ra) POUR REGULER DES REPONSES IMMUNITAIRES
|
WO2003054143A2
(fr)
*
|
2001-10-25 |
2003-07-03 |
Neurogenetics, Inc. |
Genes et polymorphismes sur le chromosome 10, associes a la maladie d'alzheimer et a d'autres maladies neurodegeneratives
|
US20030170678A1
(en)
*
|
2001-10-25 |
2003-09-11 |
Neurogenetics, Inc. |
Genetic markers for Alzheimer's disease and methods using the same
|
US20030224380A1
(en)
*
|
2001-10-25 |
2003-12-04 |
The General Hospital Corporation |
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
|
US7175983B2
(en)
*
|
2001-11-02 |
2007-02-13 |
Abmaxis, Inc. |
Adapter-directed display systems
|
EP1468288A4
(fr)
|
2001-11-20 |
2006-03-15 |
Univ Missouri |
Compositions et methodes pour le diagnostic precoce precis de la grossesse
|
US7157049B2
(en)
*
|
2001-11-20 |
2007-01-02 |
Nagaoka & Co., Ltd. |
Optical bio-discs and fluidic circuits for analysis of cells and methods relating thereto
|
US6952704B2
(en)
*
|
2001-11-26 |
2005-10-04 |
Microsoft Corporation |
Extending a directory schema independent of schema modification
|
EP2077277A1
(fr)
|
2002-02-01 |
2009-07-08 |
Schering Corporation |
Utilisation de cytokine mammifère, réactifs associés
|
WO2003072799A2
(fr)
|
2002-02-22 |
2003-09-04 |
The Government Of The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Frere du regulateur de sites marques (boris)
|
US7053188B2
(en)
|
2002-02-22 |
2006-05-30 |
Purdue Research Foundation |
Monoclonal antibodies specific for neoplasia-specific NADH:disulfide reductase
|
US7332585B2
(en)
|
2002-04-05 |
2008-02-19 |
The Regents Of The California University |
Bispecific single chain Fv antibody molecules and methods of use thereof
|
CA2391438A1
(fr)
*
|
2002-05-01 |
2003-11-01 |
Procyon Biopharma Inc. |
Reactifs et methodes diagnostiques a base de psp94
|
US7534580B2
(en)
*
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
CA2483958A1
(fr)
*
|
2002-05-02 |
2003-11-13 |
Aspenbio, Inc. |
Detection de la gravidite
|
CA2484676A1
(fr)
*
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Muteines de proteines d'ancrage de kinase, leurs peptides, et procedes associes
|
NZ537328A
(en)
*
|
2002-05-31 |
2008-04-30 |
Genetic Technologies Ltd |
Maternal antibodies as fetal cell markers to identify and enrich fetal cells from maternal blood
|
US7504215B2
(en)
|
2002-07-12 |
2009-03-17 |
Affymetrix, Inc. |
Nucleic acid labeling methods
|
DE60336023D1
(de)
|
2002-07-15 |
2011-03-24 |
Univ Texas |
Screening kombinatorischer proteinbibliotheken mittels periplasmatischer expression
|
MX337052B
(es)
|
2002-07-15 |
2016-02-11 |
Univ Texas |
Peptidos que se enlazan a fosfatidiletanolamina y sus usos en el tratamiento de infecciones virales y del cancer.
|
US7794716B2
(en)
|
2002-07-25 |
2010-09-14 |
Glenveigh Pharmaceuticals, Llc |
Antibody composition and passive immunization against pregnancy-induced hypertension
|
AU2003264033A1
(en)
*
|
2002-08-10 |
2004-02-25 |
Biogen Idec Ma Inc. |
Nogo receptor antagonists
|
EP2026070A1
(fr)
|
2002-09-09 |
2009-02-18 |
Arbor Vita Corporation |
Méthodes de diagnostiquer le cancer de col de l'utérus
|
US20050042621A1
(en)
*
|
2002-09-27 |
2005-02-24 |
Affymetrix, Inc. |
Method for preparing a nucleic acid sample for hybridization to an array
|
AU2003274373A1
(en)
|
2002-10-24 |
2004-05-13 |
Sterix Limited |
Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
|
BR0215954A
(pt)
|
2002-11-26 |
2005-09-13 |
Uc Tech |
Métodos de redução da possibilidade de mortalidade em um animal, de expressão virulenta em um patógeno intestinal, e da expressão de adesina / lectina pa-i em uma célula bacteriana, de inibição de expressão de adesina / lectina pa-i em um patógeno intestinal, de ativação induzida por intestino de adesina / lectina pa-i, de mudança morfológica induzida por c4-hsl de um patógeno intestinal, e de aderência de célula bacteriana em um intestino de mamìfero, de melhoria de patogênese intestinal, de prevenção de uma doença ou condição anormal, de infecção de pele e respiratória, de uma doença sexualmente transmitida, de um distúrbio de trato digestivo, de perda de capacidade lactante em um animal, e de desenvolvimento de um distúrbio epitelial mediado por micróbio em uma animal de idade de amamentação, de irrigação de pelo menos uma porção do trato urinário, e para monitoração da administração de poli (etileno-glicol) (peg) a um animal, composição farmacêutica, kits para a prevenção ou tratamento terapêutico de sepsia derivada de intestino, e para a monitoração da administração de poli (etileno-glicol), e, preservativo
|
EP3000899A1
(fr)
|
2002-12-04 |
2016-03-30 |
Applied Biosystems, LLC |
Amplification multiplexe de polynucléotides
|
US20040229245A1
(en)
*
|
2003-01-06 |
2004-11-18 |
Anton Bittner |
Methods and algorithms for performing quality control during gene expression profiling on DNA microarray technology
|
US7955814B2
(en)
*
|
2003-01-17 |
2011-06-07 |
Danisco A/S |
Method
|
DE602004030000D1
(de)
*
|
2003-01-17 |
2010-12-23 |
Danisco |
Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel
|
US20050196766A1
(en)
*
|
2003-12-24 |
2005-09-08 |
Soe Jorn B. |
Proteins
|
DK1748074T3
(da)
|
2003-01-17 |
2012-03-05 |
Danisco |
Fremgangsmåde til in situ-fremstilling af en emulgator i en fødevare
|
US20050014249A1
(en)
*
|
2003-02-21 |
2005-01-20 |
Norbert Staimer |
Chromatographic analysis on optical bio-discs and methods relating thereto
|
WO2004106925A2
(fr)
*
|
2003-03-03 |
2004-12-09 |
Nagaoka & Co.Ltd. |
Procedes et appareil utilises pour la detection et la quantification de divers types de cellules et utilisation d'un bio-disque optique pour leur mise en oeuvre
|
AU2004217872B2
(en)
*
|
2003-03-05 |
2010-03-25 |
Genetic Technologies Limited |
Identification of fetal DNA and fetal cell markers in maternal plasma or serum
|
US20070141570A1
(en)
*
|
2003-03-07 |
2007-06-21 |
Sequenom, Inc. |
Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
|
WO2004096157A2
(fr)
|
2003-03-07 |
2004-11-11 |
New England Medical Center Hospitals, Inc. |
Traitement de maladies a depot d'iga1
|
DK1610678T3
(da)
|
2003-04-04 |
2011-10-24 |
Yeda Res & Dev |
Antistoffer til inhibering af aktiviteten af MMP-2 og MMP-9
|
EP1615654A2
(fr)
*
|
2003-04-16 |
2006-01-18 |
Yale University |
Traitement d'etats impliquant des plaques amyloides
|
US20050221383A1
(en)
|
2003-08-08 |
2005-10-06 |
Choong-Chin Liew |
Osteoarthritis biomarkers and uses thereof
|
US20050064479A1
(en)
*
|
2003-08-12 |
2005-03-24 |
Affymetrix, Inc. |
Compounds and methods for post incorporation labeling of nucleic acids
|
AU2004265661A1
(en)
|
2003-08-14 |
2005-02-24 |
Exelixis, Inc. |
SULFs as modifiers of the beta catenin pathway and methods of use
|
DE602004030586D1
(de)
|
2003-09-15 |
2011-01-27 |
Oklahoma Med Res Found |
Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
US20050227251A1
(en)
|
2003-10-23 |
2005-10-13 |
Robert Darnell |
Method of purifying RNA binding protein-RNA complexes
|
PE20090047A1
(es)
|
2003-11-10 |
2009-01-26 |
Schering Corp |
Anticuerpo recombinante humanizado anti-interleuquina 10
|
CA2551560A1
(fr)
|
2003-12-23 |
2005-07-14 |
Arbor Vita Corporation |
Anticorps pour des souches oncogenes du hpv et leurs methodes d'utilisation
|
US7718408B2
(en)
*
|
2003-12-24 |
2010-05-18 |
Danisco A/S |
Method
|
BRPI0417533B1
(pt)
|
2003-12-24 |
2016-03-01 |
Danisco |
enzima variante glicolipídio aciltransferase, uso e método para sua produção, método para o preparo de um produto alimentício e produto assado de farinha, processo de refinamento enzimático
|
GB0716126D0
(en)
*
|
2007-08-17 |
2007-09-26 |
Danisco |
Process
|
US20050141843A1
(en)
*
|
2003-12-31 |
2005-06-30 |
Invitrogen Corporation |
Waveguide comprising scattered light detectable particles
|
US20050186646A1
(en)
*
|
2004-01-26 |
2005-08-25 |
Cruz Miguel A. |
Rapid assay to detect ADAMTS-13 activity
|
US7344701B2
(en)
*
|
2004-02-03 |
2008-03-18 |
Biosearch Technologies, Inc. |
Xanthene dyes
|
EP1730173A4
(fr)
*
|
2004-02-18 |
2008-10-08 |
Merck & Co Inc |
Molecules d'acide nucleique codant de nouvelles proteines murines a canal de calcium active faible tension, 1h alpha specialise, proteines codees et procedes d'utilisation de celles-ci
|
GB0403864D0
(en)
|
2004-02-20 |
2004-03-24 |
Ucl Ventures |
Modulator
|
EP1721011A1
(fr)
|
2004-03-01 |
2006-11-15 |
Applera Corporation |
Techniques, compositions et kits d'amplification de polynucleotide
|
GB0405637D0
(en)
|
2004-03-12 |
2004-04-21 |
Danisco |
Protein
|
JP2007533755A
(ja)
*
|
2004-04-20 |
2007-11-22 |
ザ ユニヴァーシティ オヴ シカゴ |
高分子量peg様化合物を含む治療薬送達システム
|
US8586294B2
(en)
|
2004-05-18 |
2013-11-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Detection of protein translocation by beta-galactosidase reporter fragment complementation
|
MXPA06013834A
(es)
|
2004-05-28 |
2007-03-01 |
Agensys Inc |
Anticuerpos y moleculas relacionadas que enlazan a proteinas psca.
|
US8034553B2
(en)
|
2004-06-24 |
2011-10-11 |
Kimberly-Clark Worldwide, Inc. |
Biomarkers for wound healing
|
EP2267108A1
(fr)
|
2004-07-16 |
2010-12-29 |
Danisco A/S |
Procedé de démucilagination de l'huile par des enzymes
|
WO2006015365A1
(fr)
*
|
2004-07-30 |
2006-02-09 |
Mount Sinai School Of Medicine Of New York University |
Inhibiteurs de npc1l1 et npc1l1 et procedes d'utilisation associes
|
US20060073168A1
(en)
*
|
2004-08-11 |
2006-04-06 |
Stephens David S |
Neisseria meningitidis serogroup a capsular polysaccharide acetyltransferase, methods and compositions
|
DK2386640T3
(en)
|
2004-08-26 |
2015-04-27 |
Engeneic Molecular Delivery Pty Ltd |
The making of functional nucleic acids into mammalian cells via bacterially derived intact minicells
|
FI20050753A
(fi)
|
2004-09-03 |
2006-03-04 |
Licentia Oy |
Uudet peptidit
|
DE602005021525D1
(de)
|
2004-09-14 |
2010-07-08 |
Univ Colorado |
R behandlung mit bucindolol
|
JP5085326B2
(ja)
|
2004-09-18 |
2012-11-28 |
ユニバーシティ オブ メリーランド,ボルチモア |
NCCa−ATPチャネルを標的とする処置剤およびその使用方法
|
US10583094B2
(en)
|
2004-09-18 |
2020-03-10 |
University Of Maryland |
Therapeutic methods that target the NCCA-ATP channel
|
BRPI0516011A
(pt)
|
2004-09-24 |
2008-08-19 |
Amgen Inc |
moléculas fc modificadas
|
GB0422052D0
(en)
|
2004-10-04 |
2004-11-03 |
Dansico As |
Enzymes
|
US7390489B2
(en)
*
|
2004-10-08 |
2008-06-24 |
Komed Co., Ltd. |
Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody
|
GB0423139D0
(en)
|
2004-10-18 |
2004-11-17 |
Danisco |
Enzymes
|
WO2006050270A2
(fr)
*
|
2004-11-02 |
2006-05-11 |
The Government Of The United States Of America As Represented By The Secretary Department Of Health & Human Services |
Compositions et procedes pour traiter des etats hyperproliferatifs
|
GB0424940D0
(en)
|
2004-11-11 |
2004-12-15 |
Danisco |
Transcription factors
|
US8809287B2
(en)
*
|
2004-11-15 |
2014-08-19 |
Icahn School Of Medicine At Mount Sinai |
Compositions and methods for altering Wnt autocrine signaling
|
CA2589885A1
(fr)
|
2004-12-03 |
2006-06-08 |
Schering Corporation |
Biomarqueurs pour la preselection de patients pour la therapie contre le recepteur du facteur de croissance semblable a l'insuline 1
|
US7504769B2
(en)
*
|
2004-12-16 |
2009-03-17 |
E. I. Du Pont De Nemours + Company |
Aromatic chalcogen compounds and their use
|
EP2520669A3
(fr)
|
2005-02-07 |
2013-02-27 |
GeneNews Inc. |
Biomarqueurs de l'ostéoarthrite douce et leurs utilisations
|
GB0503546D0
(en)
*
|
2005-02-21 |
2005-03-30 |
Hellenic Pasteur Inst |
Antibody
|
AU2006230563B8
(en)
|
2005-03-31 |
2010-06-17 |
Agensys, Inc. |
Antibodies and related molecules that bind to 161P2F10B proteins
|
CA2603481C
(fr)
|
2005-04-04 |
2019-03-12 |
Biogen Idec Ma Inc. |
Procedes et produits pour evaluer une reponse immunitaire a un agent therapeutique
|
US20130022979A1
(en)
|
2005-04-18 |
2013-01-24 |
Genesis Genomics Inc. |
3.4kb MITOCHONDRIAL DNA DELETION FOR USE IN THE DETECTION OF CANCER
|
ATE484589T1
(de)
|
2005-04-18 |
2010-10-15 |
Mitomics Inc |
Mitochondriale mutationen und umlagerungen als diagnostisches werkzeug zum nachweis von sonneneinstrahlung, prostatakrebs und anderen krebserkrankungen
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
ES2511218T5
(es)
|
2005-06-20 |
2017-12-07 |
Advanced Cell Diagnostics, Inc. |
Kits y productos para detección de ácidos nucleicos en células individuales y para identificación de células raras en grandes poblaciones de células heterogéneas
|
WO2007019541A2
(fr)
*
|
2005-08-08 |
2007-02-15 |
Onconon, Llc. |
Compositions d'anticorps, methodes de traitement de maladie neoplasique et methodes de regulation de la fertilite
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
PL1931710T3
(pl)
|
2005-08-31 |
2017-06-30 |
Merck Sharp & Dohme Corp. |
Przeciwciała anty-il-23 skonstruowane techniką inżynierii genetycznej
|
US7608395B2
(en)
|
2005-09-15 |
2009-10-27 |
Baylor Research Institute |
Systemic lupus erythematosus diagnostic assay
|
WO2007041340A2
(fr)
*
|
2005-09-30 |
2007-04-12 |
The Trustees Of Columbia University In The City Of New York |
Cellules microfluidiques a arrangements paralleles de molecules d'adn individuelles
|
US20070202515A1
(en)
*
|
2005-10-12 |
2007-08-30 |
Pathologica, Llc. |
Promac signature application
|
TW200730825A
(en)
|
2005-10-21 |
2007-08-16 |
Genenews Inc |
Method and apparatus for correlating levels of biomarker products with disease
|
CN101500592A
(zh)
|
2005-11-07 |
2009-08-05 |
斯克利普斯研究院 |
控制组织因子信号转导特异性的组合物和方法
|
WO2007061684A1
(fr)
|
2005-11-18 |
2007-05-31 |
Board Of Regents, The University Of Texas System |
Quantification de proteines hybrides issues d'une translocation chromosomiques et de leur activite
|
CN101326292A
(zh)
|
2005-12-08 |
2008-12-17 |
诺瓦提斯公司 |
Fgfr3抑制物对基因转录的影响
|
US20070134814A1
(en)
*
|
2005-12-09 |
2007-06-14 |
Kajander E O |
Methods and compositions for the detection of calcifying nano-particles, identification and quantification of associated proteins thereon, and correlation to disease
|
EP2674440B1
(fr)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Ensembles bioactifs à base d'immunoglobuline multivalent
|
EP1976869A2
(fr)
*
|
2005-12-23 |
2008-10-08 |
Partnership&Corp. Technology Transfer |
Peptides synthetiques utilises comme inhibiteurs de la secretion des neurotransmetteurs et comme inducteurs de la relaxation musculaire
|
US7465544B2
(en)
*
|
2006-01-11 |
2008-12-16 |
Wisconsin Alumni Research Foundation |
Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
|
DK1981902T3
(en)
|
2006-01-27 |
2015-10-05 |
Biogen Ma Inc |
Nogo Receptor Antagonists
|
TW200738752A
(en)
|
2006-01-31 |
2007-10-16 |
Bayer Schering Pharma Ag |
Modulation of MDL-1 activity for treatment of inflammatory disease
|
PL1986661T3
(pl)
|
2006-02-08 |
2019-02-28 |
Genzyme Corporation |
Terapia genowa choroby Niemanna-Picka typu A
|
EP1988921A4
(fr)
|
2006-02-28 |
2010-02-10 |
Elan Pharm Inc |
Méthodes pour traiter des maladies inflammatoires et auto-immunes avec du natalizumab
|
KR20080104343A
(ko)
|
2006-03-03 |
2008-12-02 |
엘란 파마슈티칼스, 인크. |
나탈리주마브로 염증 및 자가면역 질환을 치료하는 방법
|
WO2007109733A2
(fr)
|
2006-03-21 |
2007-09-27 |
The Johns Hopkins University |
Marqueurs de diagnostic et de pronostic et strategies de traitement de la sclerose en plaques
|
US20070232556A1
(en)
*
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
CN101578297A
(zh)
*
|
2006-04-07 |
2009-11-11 |
美国政府健康及人类服务部 |
治疗肿瘤疾病的抗体组合物和方法
|
FR2900341B1
(fr)
*
|
2006-04-27 |
2012-09-14 |
Centre Nat Rech Scient |
Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer
|
AU2007249620A1
(en)
*
|
2006-05-09 |
2007-11-22 |
Musc Foundation For Research Development |
Detecting diastolic heart failure by protease and protease inhibitor plasma profiling
|
JP5385135B2
(ja)
|
2006-07-03 |
2014-01-08 |
チャールズ デイビッド アデア, |
細胞接着分子の発現を調節するための組成物
|
US20080026394A1
(en)
*
|
2006-07-11 |
2008-01-31 |
Antara Biosciences Inc. |
Methods of detecting one or more cancer markers
|
US8445222B2
(en)
*
|
2006-07-11 |
2013-05-21 |
Musc Foundation For Research Development |
Predicting heart failure following myocardial infarction by protease and protease inhibitor profiling
|
AU2007275873B2
(en)
|
2006-07-14 |
2012-06-14 |
Chemocentryx, Inc. |
Triazolyl phenyl benzenesulfonamides
|
JP2008043332A
(ja)
|
2006-08-17 |
2008-02-28 |
Panomics Inc |
組織スライドからの核酸定量
|
EP2061900A2
(fr)
|
2006-08-25 |
2009-05-27 |
Oncotherapy Science, Inc. |
Marqueurs pronostiques et cibles thérapeutiques s'appliquant au cancer du poumon
|
US7951776B2
(en)
|
2006-09-01 |
2011-05-31 |
American Type Culture Collection |
Methods for treatment of type 1 diabetes
|
JP2008111824A
(ja)
*
|
2006-09-01 |
2008-05-15 |
Nox Technologies Inc |
腫瘍特異的tNOXアイソフォーム及び方法
|
US7985542B2
(en)
*
|
2006-09-07 |
2011-07-26 |
Institut Pasteur |
Genomic morse code
|
EP2067043B1
(fr)
*
|
2006-09-08 |
2013-07-17 |
University of Oxford |
Diagnostic clinique d'une fibrose hépatique en utilisant l'inter-alpha-trypsin inhibitor heavy chain h4
|
US8050516B2
(en)
*
|
2006-09-13 |
2011-11-01 |
Fluidigm Corporation |
Methods and systems for determining a baseline during image processing
|
US8055034B2
(en)
*
|
2006-09-13 |
2011-11-08 |
Fluidigm Corporation |
Methods and systems for image processing of microfluidic devices
|
DK2074230T3
(da)
*
|
2006-10-11 |
2013-02-25 |
Janssen Pharmaceutica Nv |
Sammensætninger og fremgangsmåder til behandling og diagnosticering af colon irritabile
|
EP1912067A1
(fr)
*
|
2006-10-12 |
2008-04-16 |
Eppendorf Array Technologies S.A. |
Procédé de quantification d'un composé cible issu d'un échantillon biologique à l'aide de puces à microreseau
|
EP2426199A3
(fr)
|
2006-10-20 |
2012-08-22 |
Danisco US Inc. |
Oxydases de polyol
|
US7776605B2
(en)
|
2006-10-26 |
2010-08-17 |
Abbott Laboratories |
Assay for cardiac troponin autoantibodies
|
US20080305512A1
(en)
*
|
2006-10-26 |
2008-12-11 |
Mattingly Phillip G |
Assay for cardiac troponin autoantibodies
|
EP2097750A2
(fr)
*
|
2006-10-26 |
2009-09-09 |
Abbott Laboratories |
Analyse immunologique d'analytes dans des echantillons contenant des anticorps anti-analytes endogenes
|
JP2010507384A
(ja)
|
2006-10-27 |
2010-03-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
キナーゼ阻害剤のプロファイリング方法
|
CA2668235A1
(fr)
|
2006-11-02 |
2008-06-05 |
Yale University |
Estimation de la competence d'ovocytes
|
US8293684B2
(en)
*
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
US8473216B2
(en)
*
|
2006-11-30 |
2013-06-25 |
Fluidigm Corporation |
Method and program for performing baseline correction of amplification curves in a PCR experiment
|
EP2102239B1
(fr)
|
2006-11-30 |
2012-04-25 |
Research Development Foundation |
Bibliothèques d'immunoglobulines améliorées
|
RU2487338C2
(ru)
*
|
2006-12-12 |
2013-07-10 |
Конинклейке Филипс Электроникс Н.В. |
Микроэлектронное сенсорное устройство для обнаружения частиц-меток
|
JP5059119B2
(ja)
|
2006-12-14 |
2012-10-24 |
シェーリング コーポレイション |
操作された抗tslp抗体
|
US8506499B2
(en)
*
|
2007-01-04 |
2013-08-13 |
Musc Foundation For Research Development |
Predicting atrial fibrillation recurrence by protease and protease inhibitor profiling
|
US8642295B2
(en)
*
|
2007-01-11 |
2014-02-04 |
Erasmus University Medical Center |
Circular chromosome conformation capture (4C)
|
EP2111224B1
(fr)
|
2007-01-12 |
2016-07-13 |
University of Maryland, Baltimore |
Ciblage de canal ncca-atp destiné à protéger les organes après un épisode ischémique
|
EP2405007B1
(fr)
|
2007-01-25 |
2013-12-04 |
DuPont Nutrition Biosciences ApS |
Production d'une lipide acyltransferase à partir de cellules transformées de Bacillus licheniformis
|
US20100055724A1
(en)
|
2007-01-26 |
2010-03-04 |
University Of Louisville Research Foundation, Inc. |
Methods of detecting autoantibodies for diagnosing and characterizing disorders
|
US8143046B2
(en)
*
|
2007-02-07 |
2012-03-27 |
Danisco Us Inc., Genencor Division |
Variant Buttiauxella sp. phytases having altered properties
|
US20080220498A1
(en)
*
|
2007-03-06 |
2008-09-11 |
Cervin Marguerite A |
Variant Buttiauxella sp. phytases having altered properties
|
KR100855299B1
(ko)
*
|
2007-02-16 |
2008-08-29 |
건국대학교 산학협력단 |
인간 il-32 특이 항원결정기를 갖는 단일클론항체,특이항체분비 융합 세포주 및 항체들을 이용한 il-32측정법
|
MX2009009079A
(es)
|
2007-02-23 |
2009-08-31 |
Schering Corp |
Anticuerpos anti-il-23p19 de ingenieria.
|
MX2009009080A
(es)
|
2007-02-23 |
2009-11-02 |
Schering Corp |
Anticuerpos anti-interleucina-23p19 manipulados por ingenieria genetica.
|
MX2009009283A
(es)
|
2007-02-28 |
2009-11-18 |
Schering Corp |
Anticuerpos anti-interleuquina -23r de ingenieria.
|
CA2680556A1
(fr)
|
2007-03-12 |
2008-09-18 |
Miraculins Inc. |
Biomarqueurs du cancer de la prostate et utilisations de ceux-ci
|
CA2682704C
(fr)
|
2007-03-30 |
2014-07-08 |
Engeneic Molecular Delivery Pty. Ltd. |
Minicellules intactes d'origine bacterienne englobant un acide nucleique fonctionnel exempt de plasmide pour administration in vivo a des cellules de mammifere
|
JP5684563B2
(ja)
|
2007-04-06 |
2015-03-11 |
ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company |
カルバペネマーゼ遺伝子の同定のための組成物および方法
|
WO2008127710A2
(fr)
|
2007-04-13 |
2008-10-23 |
Dana Farber Cancer Institute |
Méthodes de traitement d'un cancer résistant à des agents thérapeutiques anti-erbb
|
US8003314B2
(en)
|
2007-04-16 |
2011-08-23 |
Diagnostic Hybrids, Inc. |
Methods for direct fluorescent antibody virus detection in liquids
|
EP2155789B1
(fr)
|
2007-05-01 |
2013-07-24 |
Research Development Foundation |
Banques d'immunoglobulines fc
|
CA2688548A1
(fr)
*
|
2007-05-02 |
2009-01-15 |
Emory University |
Amelioration d'incorporation de glycoproteine dans des particules de type viral
|
WO2008150496A2
(fr)
*
|
2007-05-31 |
2008-12-11 |
Genelux Corporation |
Essai de sensibilité à des agents chimiothérapeutiques
|
US7776877B2
(en)
*
|
2007-06-22 |
2010-08-17 |
Chemocentryx, Inc. |
N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
|
WO2009000089A1
(fr)
*
|
2007-06-28 |
2008-12-31 |
University Of Saskatchewan |
Compositions immunomodulantes et procédés de traitement d'une maladie par des peptides de défense modifiés de l'hôte
|
KR101790908B1
(ko)
|
2007-07-12 |
2017-10-26 |
케모센트릭스, 인크. |
염증의 치료를 위한 ccr2 조절물질로서 융합된 헤테로아릴 피리딜과 페닐 벤젠술폰아마이드
|
US8293685B2
(en)
|
2007-07-26 |
2012-10-23 |
The Regents Of The University Of California |
Methods for enhancing bacterial cell display of proteins and peptides
|
EP2185718B1
(fr)
|
2007-08-03 |
2017-10-04 |
MUSC Foundation For Research Development |
Anticorps monoclonaux humains et procédés de production
|
WO2009021054A2
(fr)
|
2007-08-06 |
2009-02-12 |
Orion Genomics Llc |
Nouveaux polymorphismes nucléotidiques uniques et combinaisons de nouveaux polymorphismes connus permettant de déterminer l'expression spécifique d'allèle du gène igf2
|
RU2488592C2
(ru)
|
2007-08-08 |
2013-07-27 |
Дзе Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем |
Пептиды направленного действия на vegfr-1/nrp-1
|
US8067164B2
(en)
*
|
2007-08-12 |
2011-11-29 |
Integrated Dna Technologies, Inc. |
Microarray system with improved sequence specificity
|
US20090136916A1
(en)
*
|
2007-08-13 |
2009-05-28 |
Trustees Of Tufts College |
Methods and microarrays for detecting enteric viruses
|
US8114681B2
(en)
|
2007-10-05 |
2012-02-14 |
Affymetrix, Inc. |
Highly multiplexed particle-based assays
|
MX2010007530A
(es)
|
2008-01-10 |
2010-11-10 |
Res Dev Foundation |
Vacunas y diagnosticos para ehrlichiosis.
|
EP2252312B1
(fr)
|
2008-02-07 |
2014-04-09 |
Cornell University |
Procédé de prévention ou de traitement de la résistance à l'insuline
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
US20090311695A1
(en)
*
|
2008-03-12 |
2009-12-17 |
Talat Nasim |
Method
|
NZ588658A
(en)
|
2008-03-28 |
2012-10-26 |
Mitomics Inc |
Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
|
EP2107125A1
(fr)
|
2008-03-31 |
2009-10-07 |
Eppendorf Array Technologies SA (EAT) |
PCR en temps réel de cibles sur un micro-réseau
|
GB0807161D0
(en)
*
|
2008-04-18 |
2008-05-21 |
Danisco |
Process
|
EP2274592A4
(fr)
*
|
2008-04-23 |
2011-09-07 |
Luminex Corp |
Méthode de création d un étalon pour plusieurs analytes présents dans une matière première d origine biologique
|
WO2009132124A2
(fr)
|
2008-04-24 |
2009-10-29 |
The Trustees Of Columbia University In The City Of New York |
Motifs géométriques et bicouches lipidiques utilisables pour l'organisation de molécules d'adn et leurs utilisations
|
US20090270269A1
(en)
*
|
2008-04-28 |
2009-10-29 |
Ashok Kumar |
Nano-scale fluoro-biosensors exhibiting a low false alarm rate for rapid detection of biological contaminants
|
EP2281034B1
(fr)
|
2008-04-30 |
2015-10-21 |
DuPont Nutrition Biosciences ApS |
Procédé d'utilisation de l'alcool déshydrogénase de la Pseudoglucanobacter saccharoketogenes
|
CN102037005B
(zh)
*
|
2008-05-22 |
2017-03-29 |
国家科学研究中心 |
改善治疗功效的新光学纯化合物
|
WO2010036323A1
(fr)
|
2008-09-25 |
2010-04-01 |
University Of Massachusetts Medical School |
Procédé d'identification des interactions entre des loci génomiques
|
EP2350131B1
(fr)
|
2008-11-07 |
2017-06-07 |
Research Development Foundation |
Compositions et méthodes pour l'inhibition de la formation et de la signalisation du complexe cripto/grp78
|
EP2370092A1
(fr)
|
2008-12-03 |
2011-10-05 |
Research Development Foundation |
Modulation de l'angiogenèse à médiation par olfml-3
|
CN106905429A
(zh)
|
2008-12-05 |
2017-06-30 |
阿布拉西斯生物科学有限责任公司 |
结合SPARC的scFv
|
US20120003664A1
(en)
|
2008-12-09 |
2012-01-05 |
Uffe Lovborg |
Method for evaluating pre-treatment
|
WO2010068757A1
(fr)
|
2008-12-12 |
2010-06-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions et procédés utiles pour détecter et traiter des maladies associées à des ruptures du chromosome 16p
|
IL313131A
(en)
|
2009-02-11 |
2024-07-01 |
Caris Mpi Inc |
Molecular characterization of tumors
|
US20100286926A1
(en)
|
2009-02-11 |
2010-11-11 |
Orion Genomics Llc |
Combinations of polymorphisms for determining allele-specific expression of igf2
|
WO2010096658A1
(fr)
|
2009-02-19 |
2010-08-26 |
The Cleveland Clinic Foundation |
Corine en tant que marqueur pour une insuffisance cardiaque
|
US20100240065A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Prolyl Hydroxylase Compositions and Methods of Use Thereof
|
US8481698B2
(en)
*
|
2009-03-19 |
2013-07-09 |
The President And Fellows Of Harvard College |
Parallel proximity ligation event analysis
|
AU2010234238B2
(en)
|
2009-03-27 |
2016-07-28 |
Mdna Life Sciences Inc. |
Aberrant mitochondrial DNA, associated fusion transcripts and translation products and hybridization probes therefor
|
US20100291100A1
(en)
*
|
2009-03-27 |
2010-11-18 |
Gojo Industries, Inc. |
Compositions And Methods For Screening And Using Compounds Antagonizing Spore-Surface Interactions
|
CA2795268A1
(fr)
|
2009-04-21 |
2010-10-28 |
Genetic Technologies Limited |
Procedes d'obtention de materiel genetique ftal
|
GB0908770D0
(en)
|
2009-04-24 |
2009-07-01 |
Danisco |
Method
|
EP2425253B1
(fr)
|
2009-05-01 |
2017-03-22 |
Dako Denmark A/S |
Nouveau cocktail d'anticorps
|
EP2430451B1
(fr)
*
|
2009-05-14 |
2014-08-13 |
The Chancellors, Masters and Scholars of the University of Oxford |
Diagnostic clinique d'une fibrose hépatique / cirrhose à l'aide de biomarqueurs protéiques plasmatiques humains à faible abondance
|
US20120058222A1
(en)
|
2009-05-19 |
2012-03-08 |
Danisco A/S |
Use
|
WO2011019423A2
(fr)
|
2009-05-20 |
2011-02-17 |
Schering Corporation |
Modulation de récepteurs pilr pour traiter les infections microbiennes
|
JP5828837B2
(ja)
|
2009-06-02 |
2015-12-09 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
神経変性疾患を有する被験者において抗体により認識される小分子の同定
|
CA2766009A1
(fr)
|
2009-06-25 |
2010-12-29 |
Danisco A/S |
Enzymes lipolytiques variantes avec expression, fonctionnalite ou activite amelioree
|
DK3406717T3
(da)
|
2009-07-17 |
2020-03-16 |
Bioatla Llc |
Samtidig, integreret udvælgelse og udvikling af antistof/protein- performance og ekspression hos produktionsværter
|
EP3023438B1
(fr)
|
2009-09-03 |
2020-03-11 |
Merck Sharp & Dohme Corp. |
Anticorps anti-gitr
|
WO2011038403A1
(fr)
|
2009-09-28 |
2011-03-31 |
Yuling Luo |
Procédés de détection de séquences d'acide nucléique à spécificité élevée
|
WO2011044186A1
(fr)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Récepteurs de lymphocytes t à chaîne unique humains
|
AU2010303156B2
(en)
|
2009-10-11 |
2016-02-04 |
Biogen Ma Inc. |
Anti-VLA-4 related assays
|
EP2494077A4
(fr)
|
2009-10-27 |
2013-08-21 |
Caris Mpi Inc |
Profilage moléculaire pour médecine personnalisée
|
US20110143378A1
(en)
*
|
2009-11-12 |
2011-06-16 |
CyVek LLC. |
Microfluidic method and apparatus for high performance biological assays
|
GB0920089D0
(en)
|
2009-11-17 |
2009-12-30 |
Danisco |
Method
|
CN108707584A
(zh)
|
2009-11-17 |
2018-10-26 |
Musc研究发展基金会 |
针对人核仁素的人单克隆抗体
|
US8592151B2
(en)
*
|
2009-11-17 |
2013-11-26 |
Musc Foundation For Research Development |
Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids
|
US9700889B2
(en)
|
2009-11-23 |
2017-07-11 |
Cyvek, Inc. |
Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results
|
US9855735B2
(en)
|
2009-11-23 |
2018-01-02 |
Cyvek, Inc. |
Portable microfluidic assay devices and methods of manufacture and use
|
US9759718B2
(en)
|
2009-11-23 |
2017-09-12 |
Cyvek, Inc. |
PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use
|
US9500645B2
(en)
|
2009-11-23 |
2016-11-22 |
Cyvek, Inc. |
Micro-tube particles for microfluidic assays and methods of manufacture
|
JP5701894B2
(ja)
|
2009-11-23 |
2015-04-15 |
サイヴェク・インコーポレイテッド |
アッセイを行う方法及び装置
|
WO2013134742A2
(fr)
|
2012-03-08 |
2013-09-12 |
Cyvek, Inc |
Particules micro-tubulaires pour analyses microfluidiques et procédés de fabrication
|
US10065403B2
(en)
|
2009-11-23 |
2018-09-04 |
Cyvek, Inc. |
Microfluidic assay assemblies and methods of manufacture
|
US10022696B2
(en)
|
2009-11-23 |
2018-07-17 |
Cyvek, Inc. |
Microfluidic assay systems employing micro-particles and methods of manufacture
|
US9733242B2
(en)
|
2012-10-07 |
2017-08-15 |
Sevident, Inc. |
Devices for capturing analyte
|
US9910040B2
(en)
|
2012-07-09 |
2018-03-06 |
Sevident, Inc. |
Molecular nets comprising capture agents and linking agents
|
US8835120B2
(en)
*
|
2009-12-02 |
2014-09-16 |
Abbott Laboratories |
Assay for cardiac troponin-T (cTnT)
|
US8652788B2
(en)
|
2009-12-02 |
2014-02-18 |
Abbott Laboratories |
Assay for diagnosis of cardiac myocyte damage
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
US8183002B2
(en)
|
2009-12-03 |
2012-05-22 |
Abbott Laboratories |
Autoantibody enhanced immunoassays and kits
|
WO2011084357A1
(fr)
|
2009-12-17 |
2011-07-14 |
Schering Corporation |
Modulation de pilr pour le traitement de troubles immunitaires
|
GB0922377D0
(en)
|
2009-12-22 |
2010-02-03 |
Arab Gulf University The |
Mutant LDL receptor
|
US11287423B2
(en)
|
2010-01-11 |
2022-03-29 |
Biogen Ma Inc. |
Assay for JC virus antibodies
|
ES2930469T3
(es)
|
2010-01-11 |
2022-12-14 |
Biogen Ma Inc |
Ensayo para anticuerpos contra el virus jc
|
EP3216805A1
(fr)
|
2010-01-27 |
2017-09-13 |
Yeda Research and Development Co. Ltd |
Anticorps inhibant les métalloprotéines
|
US20130171621A1
(en)
|
2010-01-29 |
2013-07-04 |
Advanced Cell Diagnostics Inc. |
Methods of in situ detection of nucleic acids
|
US8574832B2
(en)
*
|
2010-02-03 |
2013-11-05 |
Massachusetts Institute Of Technology |
Methods for preparing sequencing libraries
|
KR101510413B1
(ko)
|
2010-02-08 |
2015-04-08 |
어젠시스 인코포레이티드 |
161p2f10b 단백질에 결합하는 항체 약물 컨쥬게이트
|
WO2011114251A1
(fr)
|
2010-03-18 |
2011-09-22 |
Danisco A/S |
Produits alimentaires
|
US9125931B2
(en)
|
2010-04-06 |
2015-09-08 |
Massachusetts Institute Of Technology |
Post-transcriptional regulation of RNA-related processes using encoded protein-binding RNA aptamers
|
JP2013523154A
(ja)
|
2010-04-06 |
2013-06-17 |
マサチューセッツ・インスティトュート・オブ・テクノロジー |
転写物測定値数が減少した、遺伝子発現プロファイリング
|
WO2011129382A1
(fr)
|
2010-04-16 |
2011-10-20 |
Abbott Japan Co. Ltd. |
Procédés et réactifs pour diagnostiquer la polyarthrite rhumatoïde
|
EP2567232A1
(fr)
|
2010-05-07 |
2013-03-13 |
AbbVie Inc. |
Procédés de prédiction de la sensibilité à un traitement à l'aide d'un inhibiteur de tyrosine kinase ciblé
|
US20120190563A1
(en)
|
2010-05-07 |
2012-07-26 |
Abbott Laboratories |
Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
|
US20110287458A1
(en)
|
2010-05-18 |
2011-11-24 |
The Texas A&M University System |
Method and composition for the diagnosis and monitoring of inflammatory diseases
|
WO2012006056A2
(fr)
|
2010-06-29 |
2012-01-12 |
Oregon Health & Science University |
Ccr6 en tant que biomarqueur de la maladie d'alzheimer
|
GB201011513D0
(en)
|
2010-07-08 |
2010-08-25 |
Danisco |
Method
|
EP2407242A1
(fr)
|
2010-07-13 |
2012-01-18 |
Dublin City University |
Analyse de clone directe et technologie de sélection
|
CN103153467A
(zh)
|
2010-07-16 |
2013-06-12 |
范德比尔特大学 |
用于提取、浓缩和检测分子物类的使用表面张力阀的低资源处理器
|
DK2593797T3
(da)
|
2010-07-16 |
2019-08-05 |
Bioatla Llc |
Hidtil ukendte fremgangsmåder til proteinevolution
|
KR101866844B1
(ko)
|
2010-07-23 |
2018-06-14 |
루미넥스 코포레이션 |
면역분석에서 시약의 반응성을 조절하기 위한 공동 결합
|
US9120862B2
(en)
|
2010-07-26 |
2015-09-01 |
Abbott Laboratories |
Antibodies relating to PIVKA-II and uses thereof
|
US20120071343A1
(en)
|
2010-09-20 |
2012-03-22 |
Advanced Cell Diagnostics, Inc |
Biomarkers for differentiating melanoma from benign nevus in the skin
|
TW202344270A
(zh)
|
2010-09-29 |
2023-11-16 |
美商艾澤西公司 |
與191p4d12蛋白結合之抗體藥物共軛物(adc)
|
BR112013008037A2
(pt)
|
2010-10-04 |
2019-09-24 |
Centre Nat Rech Scient |
compostos multivalentes como tratamento antibiótico
|
EP2441520A1
(fr)
|
2010-10-12 |
2012-04-18 |
Eppendorf AG |
Application en temps réel et détection basée sur un micro-réseau de cibles d'acides nucléiques dans un dosage sur puce de flux
|
CN103429755A
(zh)
|
2010-10-21 |
2013-12-04 |
领先细胞医疗诊断有限公司 |
用于原位检测核酸的超灵敏方法
|
AR084358A1
(es)
|
2010-12-27 |
2013-05-08 |
Lilly Co Eli |
Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
|
EP2659270A4
(fr)
|
2010-12-31 |
2014-05-21 |
Bioatla Llc |
Génération d'anticorps monoclonaux entiers
|
EP3216878B1
(fr)
|
2011-01-17 |
2019-04-03 |
Life Technologies Corporation |
Workflow pour la détection de ligands à l'aide d'acides nucléiques
|
WO2012103414A2
(fr)
|
2011-01-28 |
2012-08-02 |
Advanced Cell Diagnostics, Inc. |
Dosage pvh rnascope® pour la détermination du statut pvh dans les cancers de la tête et du cou et les lésions cervicales
|
AU2012214643B2
(en)
|
2011-02-07 |
2016-12-15 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides
|
US9212258B2
(en)
|
2011-02-23 |
2015-12-15 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic dendron-coils, micelles thereof and uses
|
WO2012120377A2
(fr)
|
2011-03-08 |
2012-09-13 |
King Abdullah University Of Science And Technology |
Biomarqueur moléculaire destiné à la détection précoce du cancer des ovaires
|
CN103518135B
(zh)
|
2011-03-11 |
2016-08-17 |
内布拉斯加大学董事委员会 |
冠状动脉疾病的生物标志物
|
WO2012129455A2
(fr)
|
2011-03-22 |
2012-09-27 |
Cyvek, Inc |
Dispositifs micro-fluidiques et leurs procédés de fabrication et d'utilisation
|
CN103476949A
(zh)
|
2011-03-28 |
2013-12-25 |
诺瓦提斯公司 |
与细胞周期蛋白依赖性激酶抑制剂相关的标志物
|
EP2694106B1
(fr)
|
2011-04-01 |
2017-12-13 |
ImmunoGen, Inc. |
Procédé pour augmenter l'efficacité d'une cancérothérapie ciblant folr1
|
EP2694095B1
(fr)
|
2011-04-05 |
2018-03-07 |
Longevity Biotech, Inc. |
Compositions comprenant des analogues du glucagon et leurs procédés de fabrication et d'utilisation
|
RU2013149861A
(ru)
|
2011-04-08 |
2015-05-20 |
ДАНИСКО ЮЭс, ИНК. |
Композиции
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
JP2014515476A
(ja)
|
2011-05-20 |
2014-06-30 |
アボットジャパン株式会社 |
非特異的結合を減少させるためのイムノアッセイ方法及び試薬
|
JP6457263B2
(ja)
|
2011-05-20 |
2019-01-23 |
オリゴメリックス インコーポレイテッド |
タウプロテアーゼ組成物および使用方法
|
AU2012262122B2
(en)
|
2011-05-31 |
2016-12-08 |
Biogen Ma Inc. |
Method of assessing risk of PML
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
US9835621B2
(en)
|
2011-07-14 |
2017-12-05 |
University Of Kentucky Research Foundation |
Process for detection of alzheimer's disease from a serum sample
|
US9593160B2
(en)
|
2011-07-18 |
2017-03-14 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
US8663637B2
(en)
|
2011-08-05 |
2014-03-04 |
Research Development Foundation |
Methods and compositions for modulation of Olfml3 mediated angiogenesis
|
BR112014003315A2
(pt)
|
2011-08-15 |
2017-03-01 |
Univ Chicago |
composições e métodos relacionados a anticorpos para a proteína a estafilocócica
|
EP3348575A1
(fr)
|
2011-08-16 |
2018-07-18 |
Emory University |
Agents spécifiques de liaison à jaml, anticorps, et leurs utilisations associées
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
EP2798081A1
(fr)
|
2011-12-29 |
2014-11-05 |
Baylor Research Institute |
Biomarqueurs de la maladie de kawasaki
|
AU2012367247B2
(en)
|
2012-01-24 |
2018-04-05 |
Cd Diagnostics, Inc. |
System for detecting infection in synovial fluid
|
SG10201700493XA
(en)
|
2012-02-29 |
2017-03-30 |
Chemocentryx Inc |
Pyrazol-1-yl benzene sulfonamides as ccr9 antagonists
|
RS58910B1
(sr)
|
2012-03-20 |
2019-08-30 |
Biogen Ma Inc |
Antitela koja neutrališu virus jcv
|
US20140178869A1
(en)
|
2012-04-05 |
2014-06-26 |
Advanced Cell Diagnostics, Inc. |
Detection of immunoglobulin light chain restriction by rna in situ hybridization
|
US20130280696A1
(en)
|
2012-04-23 |
2013-10-24 |
Elliott Millenson |
Devices and methods for detecting analyte in bodily fluid
|
JP6251730B2
(ja)
|
2012-04-26 |
2017-12-20 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
黄色ブドウ球菌(staphylococcusaureus)疾患の間にコアグラーゼ活性を中和する抗体に関連した組成物および方法
|
IN2014DN09417A
(fr)
|
2012-05-10 |
2015-07-17 |
Bioatla Llc |
|
SG11201408330XA
(en)
|
2012-05-24 |
2015-01-29 |
Mountgate Group Ltd |
Compositions and methods related to prevention and treatment of rabies infection
|
CA2874146C
(fr)
|
2012-06-01 |
2023-03-21 |
Icahn School Of Medicine At Mount Sinai |
Niveaux de ceramide dans le traitement et la prevention d'infections
|
US9758829B2
(en)
|
2012-06-22 |
2017-09-12 |
Htg Molecular Diagnostics, Inc. |
Molecular malignancy in melanocytic lesions
|
WO2014011398A1
(fr)
|
2012-07-09 |
2014-01-16 |
Novartis Ag |
Biomarqueurs associés à des inhibiteurs de cdk
|
EP2875078B1
(fr)
|
2012-07-18 |
2017-12-20 |
President and Fellows of Harvard College |
Modification de surfaces pour une répulsion et une liaison ciblée simultanées de fractions désirées
|
NZ741124A
(en)
|
2012-07-27 |
2019-11-29 |
Univ Illinois |
Engineering t-cell receptors
|
JP2015526078A
(ja)
|
2012-07-31 |
2015-09-10 |
ノバルティス アーゲー |
ヒト二重微小染色体2阻害剤と関連するマーカー
|
BR112015003751B1
(pt)
|
2012-08-23 |
2021-12-07 |
Agensys, Inc. |
Conjugados anticorpo-fármaco, uso dos mesmos, composição farmacêutica, vetor, anticorpos ou fragmentos de ligação ao antígeno, método para produzir os mesmos e anticorpo ou fragmento de ligação ao antígeno que se liga a 158p1d7
|
AU2013328881B2
(en)
|
2012-10-12 |
2018-03-15 |
Arizona Board Of Regents, On Behalf Of Arizona State University |
Antibody based reagents that specifically recognize toxic oligomeric forms of tau
|
US10226744B2
(en)
|
2012-10-19 |
2019-03-12 |
Danisco Us Inc |
Stabilization of biomimetic membranes
|
US9395369B2
(en)
|
2012-10-19 |
2016-07-19 |
Regents Of The University Of Minnesota |
Guinea pig cytomegalovirus (CIDMTR strain)
|
WO2014062635A1
(fr)
|
2012-10-19 |
2014-04-24 |
Novartis Ag |
Marqueurs pour la leucémie lymphoblastique aiguë
|
AU2013334583B2
(en)
|
2012-10-24 |
2018-09-13 |
Research Development Foundation |
JAM-C antibodies and methods for treatment of cancer
|
US10125373B2
(en)
|
2013-01-22 |
2018-11-13 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
AU2014212230B2
(en)
|
2013-02-01 |
2019-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (iPSCs)
|
EP2951319B1
(fr)
|
2013-02-01 |
2021-03-10 |
The Regents of the University of California |
Procédés pour assemblage du génome et phasage d'haplotype
|
US9411930B2
(en)
|
2013-02-01 |
2016-08-09 |
The Regents Of The University Of California |
Methods for genome assembly and haplotype phasing
|
WO2014130846A1
(fr)
|
2013-02-22 |
2014-08-28 |
Seungpyo Hong |
Administration d'un médicament par voie transdermique faisant appel à des micelles amphiphiles « dendron-coil »
|
TWI582239B
(zh)
|
2013-03-11 |
2017-05-11 |
諾華公司 |
與wnt抑制劑相關之標記
|
WO2014159242A1
(fr)
|
2013-03-14 |
2014-10-02 |
Novartis Ag |
Mutants de notch 3 et leurs utilisations
|
EP2970479B1
(fr)
|
2013-03-14 |
2019-04-24 |
Novartis AG |
Anticorps dirigés contre notch 3
|
US9273349B2
(en)
|
2013-03-14 |
2016-03-01 |
Affymetrix, Inc. |
Detection of nucleic acids
|
HRP20230632T1
(hr)
|
2013-03-15 |
2023-09-29 |
GLAdiator Biosciences, Inc. |
Gla domene kao terapijska sredstva
|
EP3404116B1
(fr)
|
2013-03-15 |
2022-10-19 |
The University of Chicago |
Procédés et compositions liés à l'activité des lymphocytes t
|
EP2968469A4
(fr)
|
2013-03-15 |
2016-08-31 |
Longevity Biotech Inc |
Peptides comprenant des acides aminés non endogènes et procédés de fabrication et d'utilisation associés
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
WO2014176047A1
(fr)
|
2013-04-25 |
2014-10-30 |
Novartis Ag |
Marqueurs pour des inhibiteurs de l'ezh2
|
EP3010522B1
(fr)
|
2013-05-21 |
2021-01-20 |
President and Fellows of Harvard College |
Compositions se liant à l'hème manipulées et leurs utilisations
|
US10119976B2
(en)
|
2013-05-28 |
2018-11-06 |
Biogen Ma Inc. |
Method of assessing risk of PML
|
ES2754177T3
(es)
|
2013-06-12 |
2020-04-16 |
Massachusetts Gen Hospital |
Métodos para la detección multiplexada de moléculas diana y sus usos
|
SG11201510430RA
(en)
|
2013-06-18 |
2016-01-28 |
Dnatrix Inc |
Treatment of brain cancer with oncolytic adenovirus
|
EP3013362B1
(fr)
|
2013-06-28 |
2021-08-04 |
Baylor Research Institute |
Immunothérapie par ciblage d'asgpr de cellules dendritiques pour la sclérose en plaques
|
CN105722534B
(zh)
|
2013-08-01 |
2019-05-31 |
艾更斯司股份有限公司 |
结合cd37蛋白的抗体药物偶联物(adc)
|
US9914775B2
(en)
|
2013-08-21 |
2018-03-13 |
The Board Of Regents Of The University Of Texas System |
Methods for treating inflammatory disorders or cancer metastasis by administering antibodies to connexin 43 (Cx43) hemichannels
|
JP2016536330A
(ja)
|
2013-08-30 |
2016-11-24 |
イミュノジェン, インコーポレイテッド |
葉酸受容体1の検出用の抗体及びアッセイ
|
SG11201602540XA
(en)
|
2013-10-03 |
2016-04-28 |
Oklahoma Med Res Found |
Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
|
US9476884B2
(en)
|
2013-10-04 |
2016-10-25 |
University Of Massachusetts |
Hybridization- independent labeling of repetitive DNA sequence in human chromosomes
|
EP3065775B1
(fr)
|
2013-11-08 |
2020-09-30 |
The Board of Regents of the University of Texas System |
Anticorps vh4 dirigés contre les astrocytes et les neurones de la matière grise
|
WO2015073707A1
(fr)
|
2013-11-15 |
2015-05-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Procédés de traitement d'une insuffisance cardiaque avec des agonistes de récepteur 2 d'hypocrétine
|
ES2874704T3
(es)
|
2013-11-20 |
2021-11-05 |
Univ Iowa Res Found |
Procedimiento para monitorizar la eficacia de un tratamiento de la enfermedad de Alzheimer con una isoforma de ApoE
|
MX2016006625A
(es)
|
2013-11-22 |
2016-12-02 |
Univ Illinois |
Receptores de células t humanas con alta afinidad modificados por medio de manipulación genética.
|
WO2015095604A2
(fr)
|
2013-12-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Méthodes et analyses associées à des cellules tumorales circulantes
|
CA2934039A1
(fr)
|
2013-12-19 |
2015-06-25 |
Danisco Us Inc. |
Utilisation d'hydrophobines pour augmenter le transfert de gaz dans des processus de fermentation aerobie
|
DK3092491T3
(en)
|
2014-01-07 |
2019-02-11 |
Bioatla Llc |
Proteins that are targeted orthologs
|
WO2015106281A1
(fr)
|
2014-01-13 |
2015-07-16 |
Baylor Research Institute |
Nouveaux vaccins contre le vph et maladies liées au vph
|
CA2938111C
(fr)
|
2014-01-29 |
2024-02-06 |
Dana-Farber Cancer Institute, Inc. |
Anticorps contre le domaine extracellulaire de muc1-c (muc1-c/ecd)
|
WO2015120273A1
(fr)
|
2014-02-07 |
2015-08-13 |
The General Hospital Corporation |
Diagnostic différentiel de néoplasmes hépatiques
|
US20150232935A1
(en)
|
2014-02-14 |
2015-08-20 |
The General Hospital Corporation |
Methods for diagnosing igg4-related disease
|
US20150247205A1
(en)
|
2014-02-28 |
2015-09-03 |
The General Hospital Corporation |
Diagnosis of multiple myeloma and lymphoma
|
EP2942627A1
(fr)
|
2014-05-05 |
2015-11-11 |
MicroBPlex, Inc. |
MILIEUX PRÉPARÉS AVEC DES ANTICORPS NOUVELLEMENT SYNTHÉTISÉS (MENSA) PAR DES CELLULES SéCRéTANT DES ANTICORPS RéCEMMENT PROLIFEéRéES ET LEURS UTILISATIONS
|
DK3140653T3
(da)
|
2014-05-08 |
2022-06-20 |
Novodiax Inc |
Direkte immunhistokemianalyse
|
WO2015179435A1
(fr)
|
2014-05-19 |
2015-11-26 |
Bayer Healthcare Llc |
Anticorps monoclonaux humanisés optimisés dirigés contre la protéine c activée et leurs utilisations
|
US10526641B2
(en)
|
2014-08-01 |
2020-01-07 |
Dovetail Genomics, Llc |
Tagging nucleic acids for sequence assembly
|
EP3191592A1
(fr)
|
2014-09-11 |
2017-07-19 |
Novartis AG |
Inhibition de prmt5 dans le traitement de maladies liées à une déficience en mtap
|
AU2015318018B2
(en)
|
2014-09-16 |
2017-05-11 |
Synermore Biologics (Suzhou) Co. Ltd. |
Anti-EGFR antibody and uses of same
|
IL292655B2
(en)
|
2014-10-06 |
2024-03-01 |
Chemocentryx Inc |
CCR9 chemokine receptor inhibitor for use in a method for treating or reducing the development of inflammatory bowel diseases
|
US20170253921A1
(en)
|
2014-10-13 |
2017-09-07 |
Life Technologies Corporation |
Methods, kits & compositions for determining gene copy numbers
|
BR112017007949A2
(pt)
|
2014-10-24 |
2018-01-23 |
Danisco Us Inc |
método para produção de álcool pelo uso de uma tripeptidil-peptidase
|
CN107105707B
(zh)
|
2014-10-24 |
2022-07-22 |
杜邦营养生物科学有限公司 |
脯氨酸耐受性三肽基肽酶及其用途
|
US10479997B2
(en)
|
2014-12-01 |
2019-11-19 |
Novartis Ag |
Compositions and methods for diagnosis and treatment of prostate cancer
|
WO2016089920A1
(fr)
|
2014-12-01 |
2016-06-09 |
The Broad Institute, Inc. |
Procédé de détermination in situ de proximité d'acide nucléique
|
CA2970143A1
(fr)
|
2014-12-08 |
2016-06-16 |
Berg Llc |
Utilisation de marqueurs comprenant de la filamine a dans le diagnostic et le traitement du cancer de la prostate
|
LT3065748T
(lt)
|
2014-12-23 |
2018-03-12 |
4D Pharma Research Limited |
Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui
|
SI3193901T1
(en)
|
2014-12-23 |
2018-06-29 |
4D Pharma Research Limited |
Pirin polypeptide and immune modulation
|
AU2016219511B2
(en)
|
2015-02-09 |
2020-11-12 |
Research Development Foundation |
Engineered immunoglobulin Fc polypeptides displaying improved complement activation
|
KR20170134379A
(ko)
|
2015-02-17 |
2017-12-06 |
더브테일 제노믹스 엘엘씨 |
핵산 서열 어셈블리
|
DK3262411T3
(da)
|
2015-02-25 |
2022-04-19 |
Univ Vanderbilt |
Antibody-mediated neutralization of marburg virus
|
WO2016145099A1
(fr)
|
2015-03-09 |
2016-09-15 |
Agensys, Inc. |
Conjugués anticorps-médicament (cam) se liant aux protéines flt3
|
EP3268462B1
(fr)
|
2015-03-11 |
2021-08-11 |
The Broad Institute, Inc. |
Couplage de génotype et de phénotype
|
GB2554572B
(en)
|
2015-03-26 |
2021-06-23 |
Dovetail Genomics Llc |
Physical linkage preservation in DNA storage
|
US9612534B2
(en)
|
2015-03-31 |
2017-04-04 |
Tokyo Electron Limited |
Exposure dose homogenization through rotation, translation, and variable processing conditions
|
US11180522B2
(en)
|
2015-05-08 |
2021-11-23 |
Centrillion Technology Holdings Corporation |
Disulfide-linked reversible terminators
|
MA51639A
(fr)
|
2015-06-15 |
2020-04-15 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
PE20180242A1
(es)
|
2015-06-15 |
2018-01-31 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
DK3307288T3
(da)
|
2015-06-15 |
2019-10-07 |
4D Pharma Res Ltd |
Sammensætninger omfattende bakteriestammer
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
MX2017016501A
(es)
|
2015-06-26 |
2018-03-12 |
Dupont Nutrition Biosci Aps |
Aminopeptidasas para hidrolizados de proteinas.
|
WO2017011329A1
(fr)
|
2015-07-10 |
2017-01-19 |
West Virginia University |
Marqueurs d'accident vasculaire cérébral et de gravité d'accident vasculaire cérébral
|
US10877045B2
(en)
|
2015-07-21 |
2020-12-29 |
Saint Louis University |
Compositions and methods for diagnosing and treating endometriosis-related infertility
|
EP3331572A4
(fr)
|
2015-08-04 |
2019-05-01 |
CD Diagnostics, Inc. |
Procédés de détection d'une nécrose liée à une réaction locale indésirable sur les tissus (altr)
|
WO2017024114A1
(fr)
|
2015-08-06 |
2017-02-09 |
President And Fellows Of Harvard College |
Molécules améliorées aptes à se lier à des microbes, et leurs utilisations
|
EP3337908A4
(fr)
|
2015-08-18 |
2019-01-23 |
The Broad Institute, Inc. |
Procédés et compositions permettant de changer la fonction et la structure de boucles et/ou de domaines de chromatine
|
ES2890073T3
(es)
|
2015-08-25 |
2022-01-17 |
Prothena Biosciences Ltd |
Métodos para detectar alfa-sinucleína fosforilada
|
WO2017040380A2
(fr)
|
2015-08-28 |
2017-03-09 |
Research Development Foundation |
Variants de fc d'anticorps modifiés
|
WO2017040813A2
(fr)
|
2015-09-02 |
2017-03-09 |
University Of Massachusetts |
Détection de loci de gènes comprenant des répétitions matricielles de crispr et/ou des acides ribonucléiques mono-guides polychromatiques
|
WO2017044419A1
(fr)
|
2015-09-08 |
2017-03-16 |
University Of Massachusetts |
Activité dnase h de la protéine cas9 de neisseria meningitidis
|
WO2017053567A1
(fr)
|
2015-09-22 |
2017-03-30 |
Delta Tm Technologies |
Conception de systèmes tampons personnalisés spécifiques à une protéine
|
ES2765709T3
(es)
|
2015-09-29 |
2020-06-10 |
Htg Molecular Diagnostics Inc |
Procedimientos para subtipificar el linfoma de células B difusas (DLBCL)
|
WO2017062953A1
(fr)
|
2015-10-10 |
2017-04-13 |
Intrexon Corporation |
Contrôle thérapeutique amélioré de formes d'interleukine-12 déstabilisées sensibles à la protéolyse
|
EP3913068B1
(fr)
|
2015-10-12 |
2023-08-02 |
Advanced Cell Diagnostics, Inc. |
Détection in situ de variants nucléotidiques dans des échantillons de bruit élevé et compositions et procédés associés
|
WO2017070123A1
(fr)
|
2015-10-19 |
2017-04-27 |
Dovetail Genomics, Llc |
Procédés d'assemblage de génomes, phasage d'haplotypes et détection d'acide nucléique indépendant cible
|
EP4382127A2
(fr)
|
2015-11-09 |
2024-06-12 |
The Children's Hospital of Philadelphia |
Glypican 2 en tant que marqueur du cancer et cible thérapeutique
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
DK3209310T3
(en)
|
2015-11-20 |
2018-04-16 |
4D Pharma Res Ltd |
COMPOSITIONS COMPREHENSIVE BAKERY STUES
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
US10228367B2
(en)
|
2015-12-01 |
2019-03-12 |
ProteinSimple |
Segmented multi-use automated assay cartridge
|
CA3006769A1
(fr)
|
2015-12-02 |
2017-06-08 |
Stcube & Co., Inc. |
Anticorps et molecules se liant de maniere immunospecifique a btn1a1 et leurs utilisations therapeutiques
|
CN108925136B
(zh)
|
2015-12-02 |
2022-02-01 |
斯特赛恩斯公司 |
特异于糖基化的btla(b和t淋巴细胞衰减因子)的抗体
|
ES2902477T3
(es)
|
2015-12-04 |
2022-03-28 |
Univ Texas |
Péptidos SLC45A2 para inmunoterapia
|
JOP20200228A1
(ar)
|
2015-12-21 |
2017-06-16 |
Novartis Ag |
تركيبات وطرق لخفض تعبير البروتين tau
|
WO2017112492A2
(fr)
|
2015-12-22 |
2017-06-29 |
The Regents Of The University Of Colorado, A Body Corporate |
Protection d'arn de la dégradation à l'aide d'arn viraux modifiés
|
US10337050B2
(en)
|
2016-02-11 |
2019-07-02 |
Qiagen Sciences, Llc |
Polyphenolic additives in sequencing by synthesis
|
WO2017139415A2
(fr)
|
2016-02-11 |
2017-08-17 |
Qiagen Waltham, Inc. |
Composés piégeurs pour un séquençage par synthèse amélioré
|
US20200200735A9
(en)
|
2016-02-22 |
2020-06-25 |
Ursure, Inc. |
System and method for detecting therapeutic agents to monitor adherence to a treatment regimen
|
AU2017223600B2
(en)
|
2016-02-23 |
2023-08-03 |
Dovetail Genomics Llc |
Generation of phased read-sets for genome assembly and haplotype phasing
|
WO2017147060A1
(fr)
|
2016-02-25 |
2017-08-31 |
Dupont Nutrition Biosciences Aps |
Procédé de production d'un hydrolysat protéique utilisant la tripeptidyl-peptidase aspergillus
|
US10889637B2
(en)
|
2016-02-26 |
2021-01-12 |
The Board Of Regents Of The University Of Texas System |
Methods of treating an osteolytic tumor and spinal cord injury by administering connexin (Cx) 43 hemichannel-binding antibodies
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
AU2017226831B2
(en)
|
2016-03-04 |
2018-10-04 |
4D Pharma Plc |
Compositions comprising bacterial Blautia strains for treating visceral hypersensitivity
|
EP3433262A4
(fr)
|
2016-03-25 |
2019-11-20 |
Muralidhar Reddy Moola |
Synthèse combinatoire et développement de biomarqueurs
|
US11660352B2
(en)
|
2016-03-29 |
2023-05-30 |
Stcube, Inc. |
Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof
|
CN109195990A
(zh)
|
2016-03-30 |
2019-01-11 |
Musc研究发展基金会 |
通过靶向糖蛋白a重复优势蛋白(garp)治疗和诊断癌症以及单独或联合提供有效免疫疗法的方法
|
WO2017194589A1
(fr)
|
2016-05-10 |
2017-11-16 |
Vib Vzw |
Inhibition du dysfonctionnement synaptique précoce à médiation par tau
|
EP3954771A1
(fr)
|
2016-05-13 |
2022-02-16 |
Dovetail Genomics, LLC |
Récupération d'informations de liaison de longue portée à partir d'échantillons conservés
|
US11919971B2
(en)
|
2016-05-16 |
2024-03-05 |
President And Fellows Of Harvard College |
Aqueous biomolecule coupling on CO2-plasma-activated surfaces
|
WO2017214068A1
(fr)
|
2016-06-05 |
2017-12-14 |
Berg Llc |
Systèmes et procédés de stratification de patient et identification de biomarqueurs potentiels
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
EP3487883B1
(fr)
|
2016-07-20 |
2023-01-04 |
Stcube, Inc. |
Méthodes de traitement et de thérapie du cancer utilisant une combinaison d'anticorps qui se lient à pd-l1 glycosylé
|
AU2017300579B2
(en)
|
2016-07-20 |
2023-02-09 |
Katholieke Universiteit Leuven, K.U.Leuven R&D |
Therapeutic agents for neurological and psychiatric disorders
|
WO2018085679A1
(fr)
|
2016-11-04 |
2018-05-11 |
Stave James W |
Détection directe de micro-organismes dans des échantillons de patient par dosage immunologique
|
EP3538093B1
(fr)
|
2016-11-09 |
2023-10-25 |
Qiagen Sciences, LLC |
Mélanges photoprotecteurs utilisés comme réactifs d'imagerie dans le séquençage par synthèse
|
JP7013464B2
(ja)
|
2016-11-23 |
2022-02-15 |
ケモセントリックス, インコーポレイテッド |
巣状分節性糸球体硬化症を治療する方法
|
WO2018100431A1
(fr)
|
2016-11-29 |
2018-06-07 |
Genomic Vision |
Procédé de conception d'un ensemble de séquences polynucléotidiques destiné à l'analyse d'événements spécifiques dans une région génétique d'intérêt
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
CN110462062A
(zh)
|
2017-01-26 |
2019-11-15 |
俄克拉荷马医学研究基金会 |
系统性红斑狼疮疾病活动性、强度和急性发作的生物标志物
|
US11267885B2
(en)
|
2017-01-26 |
2022-03-08 |
Zlip Holding Limited |
CD47 antigen binding unit and uses thereof
|
WO2018144425A1
(fr)
|
2017-01-31 |
2018-08-09 |
Vanderbilt University |
Génération d'anticorps monoclonaux ige spécifiques d'allergènes et d'helminthes humains pour une utilisation diagnostique et thérapeutique
|
WO2018163051A1
(fr)
|
2017-03-06 |
2018-09-13 |
Novartis Ag |
Méthodes de traitement du cancer à expression d'ubb réduite
|
PT3630136T
(pt)
|
2017-05-22 |
2021-06-11 |
4D Pharma Res Ltd |
Composições que compreendem estirpes bacterianas
|
EP3630942B1
(fr)
|
2017-05-24 |
2022-11-30 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
KR20200015602A
(ko)
|
2017-05-31 |
2020-02-12 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1에 면역특이적으로 결합하는 항체 및 분자 및 이의 치료적 용도
|
US20200131266A1
(en)
|
2017-05-31 |
2020-04-30 |
Stcube & Co., Inc. |
Methods of treating cancer using antibodies and molecules that immunospecifically bind to btn1a1
|
EP3635007A1
(fr)
|
2017-06-06 |
2020-04-15 |
STCube & Co., Inc. |
Procédés de traitement du cancer à l'aide d'anticorps et de molécules se liant à btn1a1 ou des ligands de btn1a1
|
BR112019026677A2
(pt)
|
2017-06-14 |
2020-06-30 |
4D Pharma Research Limited |
composições compreendendo cepas bacterianas
|
EP3638271B1
(fr)
|
2017-06-14 |
2020-10-14 |
4D Pharma Research Limited |
Compositions comprenant des souches bactériennes
|
US10768185B2
(en)
|
2017-07-20 |
2020-09-08 |
Trustees Of Boston University |
Tenofovir detection assay
|
EP4085919A3
(fr)
|
2017-07-21 |
2023-02-08 |
Novartis AG |
Compositions et procédés permettant de traiter un cancer
|
EP3672990A1
(fr)
|
2017-08-25 |
2020-07-01 |
Five Prime Therapeutics, Inc. |
Anticorps anti-b7-h4 et leurs procédés d'utilisation
|
KR102678252B1
(ko)
|
2017-09-01 |
2024-06-26 |
쓰촨 케룬-바이오테크 바이오파마수티컬 컴퍼니 리미티드 |
재조합 이중특이적 항체
|
JP7365704B2
(ja)
|
2017-09-05 |
2023-10-20 |
グラディエーター バイオサイエンシーズ インコーポレイテッド |
幹細胞へのペイロードの送達
|
DE112018005145T5
(de)
|
2017-09-15 |
2020-07-23 |
The Regents Of The University Of California |
Hemmung von aminoacylase 3 (aa3) bei der behandlung von krebs
|
EP3692152A4
(fr)
|
2017-10-04 |
2021-12-01 |
The Broad Institute, Inc. |
Procédés et compositions permettant de modifier la fonction et la structure de boucles et/ou de domaines de chromatine
|
MX2020003502A
(es)
|
2017-10-11 |
2021-09-30 |
Chemocentryx Inc |
Tratamiento de glomerulosclerosis segmentaria focal con antagonistas ccr2.
|
EP4116327A1
(fr)
|
2017-10-11 |
2023-01-11 |
Board Of Regents, The University Of Texas System |
Anticorps pd-l1 humains et leurs procédés d'utilisation
|
EP3706795A4
(fr)
|
2017-11-09 |
2021-10-13 |
Pinteon Therapeutics Inc. |
Méthodes et compositions pour la génération et l'utilisation d'anticorps tau phosphorylés spécifiques à une conformation humanisée
|
CN109870581B
(zh)
|
2017-12-04 |
2021-05-04 |
厦门万泰凯瑞生物技术有限公司 |
一种定量检测HBsAg的试剂盒及方法
|
EP3723786A4
(fr)
|
2017-12-15 |
2021-09-08 |
Syngenta Participations Ag |
Ligands non-anticorps pour la détection de protéines cibles
|
WO2019156758A2
(fr)
|
2018-01-05 |
2019-08-15 |
Vanderbilt University |
Neutralisation à médiation par anticorps du virus chikungunya
|
WO2019155041A1
(fr)
|
2018-02-12 |
2019-08-15 |
Vib Vzw |
ANTICORPS COMPLEXES Gβγ ET LEURS UTILISATIONS
|
US20200408771A1
(en)
|
2018-02-22 |
2020-12-31 |
The United States Of America,As Represented By The Secretary,Department Of Health And Human Services |
Cd153 and/or cd30 in infection
|
BR112020017925A2
(pt)
|
2018-03-02 |
2020-12-22 |
Five Prime Therapeutics, Inc. |
Anticorpos contra b7-h4 e métodos de uso dos mesmos
|
WO2019182896A1
(fr)
|
2018-03-23 |
2019-09-26 |
Board Of Regents, The University Of Texas System |
Anticorps à double spécificité pour pd-l1 et pd-l2 et leurs procédés d'utilisation
|
CN112292457A
(zh)
|
2018-04-09 |
2021-01-29 |
领先细胞医疗诊断有限公司 |
用于原位检测核酸的进一步增强信号放大的方法
|
US11884725B2
(en)
|
2018-04-24 |
2024-01-30 |
Ampsource Biopharma Shanghai Inc. |
Antibody against TIM-3 and application thereof
|
WO2019213276A1
(fr)
|
2018-05-02 |
2019-11-07 |
Novartis Ag |
Régulateurs de cellules souches pluripotentes humaines et leurs utilisations
|
TW202016144A
(zh)
|
2018-06-21 |
2020-05-01 |
日商第一三共股份有限公司 |
包括cd3抗原結合片段之組成物及其用途
|
KR20210061341A
(ko)
|
2018-09-13 |
2021-05-27 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
신규한 lilrb4 항체 및 이의 용도
|
WO2020069424A1
(fr)
|
2018-09-28 |
2020-04-02 |
Centrillion Technologies, Inc. |
Terminateurs réversibles à liaison disulfure
|
JP2022508716A
(ja)
|
2018-10-15 |
2022-01-19 |
ユニバーシティ オブ マサチューセッツ |
Nme2Cas9-デアミナーゼ融合タンパク質によるブログラム可能なDNA塩基編集
|
CA3116539C
(fr)
|
2018-10-18 |
2023-10-03 |
Oklahoma Medical Research Foundation |
Biomarqueurs d'indice immunitaire d'activite de maladie du lupus erythemateux dissemine (sle) qui caracterise une activite de maladie
|
JP7401538B2
(ja)
|
2018-10-22 |
2023-12-19 |
シャンハイ、ケンパーソー、バイオテクノロジー、カンパニー、リミテッド |
抗cldn18.2抗体およびその使用
|
EP3870614A1
(fr)
|
2018-10-23 |
2021-09-01 |
GlyCardial Diagnostics, S.L. |
Anticorps spécifiques de l'apoj glycosylée et leurs utilisations
|
CN111196851B
(zh)
|
2018-11-20 |
2021-11-16 |
厦门万泰凯瑞生物技术有限公司 |
针对人抗缪勒管激素的特异性抗体及其应用
|
CN113423465A
(zh)
|
2018-11-28 |
2021-09-21 |
俄勒冈健康与科学大学 |
治疗性的因子xii抗体
|
IL311084A
(en)
|
2018-11-30 |
2024-04-01 |
Caris Mpi Inc |
New generation molecular characterization
|
US20230192840A1
(en)
|
2018-12-28 |
2023-06-22 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Antibody and use thereof
|
WO2020185312A2
(fr)
|
2019-01-25 |
2020-09-17 |
President And Fellows Of Harvard College |
Compositions et procédé de synthèse d'acides nucléiques
|
EP3924501A4
(fr)
|
2019-02-15 |
2022-11-23 |
Advanced Cell Diagnostics, Inc. |
Procédés de détection multiplexe d'acides nucléiques par hybridation in situ
|
CN113474374A
(zh)
|
2019-04-16 |
2021-10-01 |
四川科伦博泰生物医药股份有限公司 |
抗FXI/FXIa抗体及其用途
|
AU2020265250A1
(en)
|
2019-04-30 |
2021-11-18 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for determining effectiveness of frataxin replacement therapy
|
WO2021016062A1
(fr)
|
2019-07-19 |
2021-01-28 |
The Children's Hospital Of Philadelphia |
Récepteurs antigéniques chimériques contenant des domaines de liaison au glypicane 2
|
JP2022541652A
(ja)
|
2019-07-26 |
2022-09-26 |
ヴァンダービルト ユニバーシティ |
エンテロウイルスd68に対するヒトモノクローナル抗体
|
US20220331363A1
(en)
|
2019-09-20 |
2022-10-20 |
Shanghai GenBase Biotechnology Co., Ltd. |
Bcma-targeted antibody and chimeric antigen receptor
|
EP4041767A1
(fr)
|
2019-09-26 |
2022-08-17 |
StCube & Co. |
Anticorps spécifiques dirigés contre ctla-4 glycosylée et leurs procédés d'utilisation
|
WO2021063201A1
(fr)
|
2019-09-30 |
2021-04-08 |
四川科伦博泰生物医药股份有限公司 |
Anticorps anti-pd-1 et son utilisation
|
WO2021072277A1
(fr)
|
2019-10-09 |
2021-04-15 |
Stcube & Co. |
Anticorps spécifiques de lag3 glycosylé et leurs procédés d'utilisation
|
US10792360B1
(en)
|
2019-11-21 |
2020-10-06 |
Chemocentryx, Inc. |
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
|
CA3163319A1
(fr)
|
2019-12-02 |
2021-06-10 |
Caris Mpi, Inc. |
Predicteur de reponse au platine dans une approche pan-cancer
|
EP4073246A4
(fr)
|
2019-12-12 |
2023-12-06 |
President And Fellows Of Harvard College |
Compositions et méthodes pour le codage à barres biomoléculaire dirigé par la lumière
|
JP2023505408A
(ja)
|
2019-12-13 |
2023-02-09 |
シチュアン ケルン-バイオテック バイオファーマシューティカル カンパニー リミテッド |
抗tslp抗体及びその使用
|
EP3842452A1
(fr)
|
2019-12-26 |
2021-06-30 |
Universitat Autònoma de Barcelona |
Protéines d'échafaudage et nanoconjugués thérapeutiques à base de nidogène
|
CN113061165A
(zh)
|
2020-01-02 |
2021-07-02 |
厦门大学 |
EB病毒BNLF2b基因编码多肽及其检测用途
|
WO2021156490A2
(fr)
|
2020-02-06 |
2021-08-12 |
Vib Vzw |
Liants du coronavirus
|
CA3166949A1
(fr)
|
2020-02-11 |
2021-08-19 |
James E. Crowe |
Anticorps monoclonaux humains diriges contre le coronavirus 2 du syndrome respiratoire aigu severe (sars-cov-2)
|
WO2021167908A1
(fr)
|
2020-02-17 |
2021-08-26 |
Board Of Regents, The University Of Texas System |
Procédés d'expansion de lymphocytes infiltrant les tumeurs et leur utilisation
|
CN115698047A
(zh)
|
2020-02-25 |
2023-02-03 |
非营利性组织佛兰芒综合大学生物技术研究所 |
富含亮氨酸的重复激酶2变构调节剂
|
WO2021195385A1
(fr)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Anticorps monoclonaux humains dirigés contre le coronavirus du syndrome respiratoire aigu sévère 2 (sras-cov-2)
|
WO2021195418A1
(fr)
|
2020-03-26 |
2021-09-30 |
Vanderbilt University |
Anticorps monoclonaux humains dirigés contre le coronavirus 2 du syndrome respiratoire aigu sévère (sars-cov-2)
|
TW202203916A
(zh)
|
2020-03-31 |
2022-02-01 |
美商卡默森屈有限公司 |
使用ccr9抑制劑及抗il—23阻斷抗體治療發炎性腸道疾病的組成物及方法
|
KR20230002943A9
(ko)
|
2020-04-22 |
2024-04-26 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
핵산 검출을 위한 등온 방법, 조성물, 키트, 및 시스템
|
US20230338565A1
(en)
|
2020-05-15 |
2023-10-26 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Antibody drug conjugate, preparation method therefor and use thereof
|
EP3939999A1
(fr)
|
2020-07-14 |
2022-01-19 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Anticorps neutralisant la sous-unité alpha du récepteur de l'interleukine 11 (il11ra) et leurs utilisations
|
WO2022047359A1
(fr)
|
2020-08-31 |
2022-03-03 |
Berg Llc |
Biomarqueurs protéiques du cancer du pancréas
|
GB202105804D0
(en)
|
2020-11-20 |
2021-06-09 |
Univ Cape Town |
Use of microvirin in the identification of mycobacterium tuberculosis mannose-capped lipoarabinomannan
|
WO2022120378A1
(fr)
|
2020-12-04 |
2022-06-09 |
University Of Tennessee Research Foundation |
Procédé de diagnostic de maladies amyloïdes
|
WO2022143743A1
(fr)
|
2020-12-31 |
2022-07-07 |
和铂医药(苏州)有限公司 |
Protéine liant un antigène lifr humain, son procédé de préparation et son utilisation
|
GB2603166A
(en)
|
2021-01-29 |
2022-08-03 |
Thelper As |
Therapeutic and Diagnostic Agents and Uses Thereof
|
MX2023008895A
(es)
|
2021-02-09 |
2023-08-09 |
Medilink Therapeutics Suzhou Co Ltd |
Conjugado de sustancia bioactiva, metodo de preparacion y uso del mismo.
|
IL305318A
(en)
|
2021-02-19 |
2023-10-01 |
Vib Vzw |
Cation-independent mannose-6-phosphate receptor binders
|
CA3212530A1
(fr)
|
2021-03-05 |
2022-09-09 |
Shanghai GenBase Biotechnology Co., Ltd. |
Anticorps anti-cldn6 et son utilisation
|
CN117729942A
(zh)
|
2021-03-08 |
2024-03-19 |
伊缪诺金公司 |
用于增加靶向adam9的免疫缀合物治疗癌症的功效的方法
|
CA3207635A1
(fr)
|
2021-03-09 |
2022-09-15 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Proteine de liaison a ror1 et son utilisation
|
CA3214821A1
(fr)
|
2021-04-06 |
2022-10-13 |
Guisong WANG |
Marqueurs proteiques pour le cancer du sein du type positif aux recepteurs des oestrogenes (er) et du type negatif aux recepteurs des oestrogenes (er)
|
WO2022216841A1
(fr)
|
2021-04-06 |
2022-10-13 |
Berg Llc |
Marqueurs protéiques pour un cancer du sein positif au récepteur des œstrogènes (er) de type luminal a (la) et de type luminal b1 (lb1)
|
CA3214833A1
(fr)
|
2021-04-06 |
2022-10-13 |
Bpgbio, Inc. |
Marqueurs proteiques pour le pronostic de la progression du cancer du sein
|
JP2024515726A
(ja)
|
2021-04-19 |
2024-04-10 |
テンプル セラピューティクス ビーブイ |
子宮内膜過剰増殖性障害および卵巣過剰増殖性障害を検出または処置するための方法
|
EP4370160A1
(fr)
|
2021-07-15 |
2024-05-22 |
President And Fellows Of Harvard College |
Compositions et méthodes associées à des cellules comprenant des particules adhérées
|
EP4377352A2
(fr)
|
2021-07-30 |
2024-06-05 |
Vib Vzw |
Liants du récepteur mannose-6-phosphate indépendants des cations pour la dégradation ciblée de protéines
|
WO2023081070A1
(fr)
|
2021-11-02 |
2023-05-11 |
University Of Massachusetts |
Protéines de fusion à domaine nme2cas9 incrusté
|
AU2022392804A1
(en)
|
2021-11-19 |
2024-05-02 |
Mirobio Limited |
Engineered PD-1 antibodies and uses thereof
|
GB202201137D0
(en)
|
2022-01-28 |
2022-03-16 |
Thelper As |
Therapeutic and diagnostic agents and uses thereof
|
EP4238988A1
(fr)
|
2022-03-01 |
2023-09-06 |
Consejo Superior De Investigaciones Científicas |
Anticorps dirigés contre le sars-cov-2 et leurs utilisations
|
US20230365708A1
(en)
|
2022-04-01 |
2023-11-16 |
Board Of Regents, The University Of Texas System |
Dual specificity antibodies to human pd-l1 and pd-l2 and methods of use therefor
|
GB202204813D0
(en)
|
2022-04-01 |
2022-05-18 |
Bradcode Ltd |
Human monoclonal antibodies and methods of use thereof
|
WO2023196866A1
(fr)
|
2022-04-06 |
2023-10-12 |
Mirobio Limited |
Anticorps cd200r modifiés et leurs utilisations
|
US20230357851A1
(en)
|
2022-04-06 |
2023-11-09 |
Larimar Therapeutics, Inc. |
Frataxin-sensitive markers for monitoring frataxin-replacement therapy
|
WO2023240201A1
(fr)
|
2022-06-08 |
2023-12-14 |
Larimar Therapeutics, Inc. |
Marqueurs sensibles à la frataxine pour surveiller la progression et le traitement du syndrome de leigh
|
WO2023239710A1
(fr)
|
2022-06-08 |
2023-12-14 |
Onkure, Inc. |
Benzopyrimidin-4 (3h)-ones en tant qu'inhibiteurs de pi3k
|
US20240010742A1
(en)
|
2022-06-10 |
2024-01-11 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
WO2024028794A1
(fr)
|
2022-08-02 |
2024-02-08 |
Temple Therapeutics BV |
Méthodes de traitement de troubles de l'endomètre et de l'hyperprolifération ovarienne
|
WO2024040020A1
(fr)
|
2022-08-15 |
2024-02-22 |
Absci Corporation |
Enrichissement de cellule spécifique à une activité d'affinité quantitative
|
WO2024038160A1
(fr)
|
2022-08-18 |
2024-02-22 |
Vib Vzw |
Moyens et méthodes pour moduler l'excitabilité neuronale
|
WO2024054469A1
(fr)
|
2022-09-08 |
2024-03-14 |
Onkure, Inc. |
Isoquinolones utilisés en tant qu'inhibiteurs de pi3k
|
WO2024064024A1
(fr)
|
2022-09-19 |
2024-03-28 |
Onkure, Inc. |
Dérivés de ((4-oxo-3,4-dihydroquinazolin-8-yl)méthyl)amine utilisés en tant qu'inhibiteurs de p13k pour le traitement du cancer
|
WO2024064002A1
(fr)
|
2022-09-20 |
2024-03-28 |
Onkure, Inc. |
Inhibiteur de hdac oki-179 destiné au traitement de cancers résultant d'une mutation de la voie mapk
|
WO2024068744A1
(fr)
|
2022-09-27 |
2024-04-04 |
Vib Vzw |
Antiviraux dirigés contre le virus parainfluenza humain
|
WO2024081345A1
(fr)
|
2022-10-14 |
2024-04-18 |
Onkure, Inc. |
Benzopyrimidin-4(3h)-ones utilisées en tant qu'inhibiteurs de pi3k
|
WO2024102466A2
(fr)
|
2022-11-11 |
2024-05-16 |
Igan Biosciences |
Agents polypeptidiques de protéase iga
|
WO2024124041A1
(fr)
|
2022-12-07 |
2024-06-13 |
Advanced Cell Diagnostics, Inc. |
Détection multiplexée de cibles d'acides nucléiques
|